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Abstract
In this dissertation we discuss two mathematical models for leptospirosis. The first project
is a mathematical model of leptospirosis with impulse actions in cattle. The project is
to understand the propagation of leptospirosis and find a schedule for control programs
to eradicate the disease in a cattle ranch. An epidemiological model has been built with
ordinary differential equations (ODEs) and included some vaccination and recruitment
control programs in the form of impulse actions to prevent the propagation of leptospirosis in
the ranch. This system of ODEs with impulse actions determines a schedule of control actions
in order to eradicate leptospirosis in the ranch. Parameter estimation and sensitivity analysis
were completed as a part of this study. The second project is a stochastic optimization model
for cost effectiveness analysis in early detection of leptospirosis in humans. To seek an optimal
treatment strategy for the patients coming into a hospital with the symptoms similar to those
of leptospirosis, a stochastic processing model with a computational algorithm was developed
to compare treatment strategies and determine an optimal management strategy maximizing
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Mathematical modeling has been widely used in many disciplines such as physics, biology
and economics to understand and interpret natural phenomena due to their reliability and
broad applicability. There are various types of mathematical modeling and each of them can
be useful depending on the objective of problem and available data. For instance, modeling
with differential equations might be useful to simulate deterministic systems in physics or
biology, and Markov chain modeling might be useful to determine strategies for the systems
with stochastic events.
Several areas of mathematical modeling have emerged according to biological problems
such as infectious diseases, interacting population, etc [33, 27]. In this dissertation, we
have developed two mathematical models for an infectious disease, leptospirosis, by using
differential equations and scientific computations with a Markov chain.
1.1 Mathematical modeling of epidemiological diseases
with differential equations
Infectious diseases are still a growing public health threat across the globe. More than 30
new infectious diseases have been identified for past 30 years [42]. The main challenge is
having the opportunity of preventing and controlling them [42]. Mathematical modeling can
1
be used as a tool to understand the spread of disease, estimate population risk, predict the
effects of interventions, and reduce the damage [13].
Mathematical modeling of infectious diseases describe interactions between individuals
or populations and other biological structures or environment. While defining these
interactions with mathematical equations, complex systems can be broken down into simple
pieces to explore deeply and analyze the consequences of different events in the systems
[13]. Several methods have been developed using mathematical tools to define these
interactions. Differential equations (DEs) have been used in physics since the end of
16th century by Newton and Leibniz, but they do not have that long history in biology
and particularly in epidemiological models. One of the first epidemiological models with
differential equations which consists of susceptible, infectious, and recovered individual
compartments was introduced by Kermack and McKendrick in 1927 [39, 27]. Susceptible
individuals are healthy, but they have potential to get infected later, infected individuals




Figure 1.1: SIR model
Kermack and McKendrick’s model was constructed based on the rate of change in each
compartment. Susceptible individuals move into the infected compartment with a certain
rate in a unit of time when they contact with infected individuals. Similarly infected
individuals move into recovered compartment with a certain rate in a unit of time when
they recover. The mathematical formulation of the model represented in Figure 1.1, is the
following:
S ′ = −βIS
I ′ = βIS − αI
R′ = αI
2
where S, I, and R respectively represent the number of susceptible, infected and recovered
individuals and β, α represent the transmission rate of disease and the recovery rate of
infected individuals. Therefore, the right hand side of system represents the rate of change
in the quantity of individuals among the compartments with respect to the unit of time.
Many other versions of epidemiological models have been developed according to various
scenarios and disease types with features such as age-structure, transmission by vectors and
space.
1.2 Disease modeling with control programs and free-
living pathogens in environment
Control programs are essential components in modeling of epidemiological diseases, for
instance, quarantine, vaccination and culling [39, 27]. These programs usually refer to
the actions to prevent the propagation of the disease and reduce the number of new
infectious. Vaccination is one of the most common control programs, and depending
on its implementation and consequences there are several different ways to formulate an
epidemiological model with vaccination [27]. For instance, the vaccination might be applied
to the entire population or to a certain compartment, and it might be applied continuously or
instantaneously. One version of a vaccine implementation with pulse actions was examined
by Shulgin at al. [56] as the following:
dS
dt






= βSI − γI − µI,
where S and I donate the number of susceptible and infected individuals, T is the interval
between pulse actions, S(nT−) represents the number of susceptible individuals in the instant
immediately prior to the nth vaccination pulse (n = 0, 1, ...). Dirac delta function, δ(t) is
zero unless t = 0. The parameters µ, β, γ are respectively birth, transmission and recovery
rates. Biological interpretation of the model is that the susceptible population continuously
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gets infected with transmission rate β, infected population continuously become recovered
with rate γ and also birth, death occurs with rate of µ during the time interval [nT, (n+1)T ],
and then susceptible population gets vaccinated instantaneously with a fraction pv at time
T . Another study with SIS (susceptible infected susceptible) compartments in a DEs model
with pulse vaccination was proposed by F. Cordova-Lepe and coworkers [45]. They modified
a function determining pulse vaccination time depending on the current incidence.
Another important component in modeling infectious diseases is the method of the
transmission. The transmission may be direct from one host to another as in Figure 1.1, but
could also be from indirect contact with pathogens in the environment. R. Breban et al. in
[9] built a SI general model with DEs by including the pathogens in the environment as a
compartment which causes indirect transmission of the diseases with a function f(V ),
dS
dt
= π − µS − ρSf(V )
dI
dt
= ρSf(V )− (µ+ γ)I
dV
dt
= ωI − ηV
where S and I denoted the number of susceptible and infected individuals and V represented
the pathogens in the environment. The parameter γ is the recovery rate of infected
individuals, η is the decay rate of the pathogen from the environment, ω is the shedding rate
of infected individuals, π is the susceptible inflow, µ is the natural death rate of individuals
and ρ is the contact rate of susceptible individuals with the environment. For pathogen
surviving in the environment for a long time, including indirect transmission is important.
The model shows the approximation of direct transmission is not sufficient to model influenza
accurately. As a result, it is essential to formulate the epidemiological model according to
the reality of corresponding transmission roots.
1.3 Leptospirosis in humans and cattle
Leptospirosis is zoonotic disease and has higher prevalence in tropical regions such as Central
and South America since the tropical conditions provide favorable conditions to the pathogen
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and increase the contact rate between pathogen and host [36, 40]. Infection occurs through
direct contact with infected individuals or indirect contact with free-living pathogens in the
environment [52, 36]. While the main reservoirs are small mammals such as rodents and
rats, domestic animals and humans are hosts as well. Particularly leptospirosis is one of the
well known diseases causing reproductive failure in cattle [52, 36].
In humans, the diagnosis of leptospirosis is challenging because most leptospirosis patients
do not have specific signs and symptoms, and the clinical manifestation varies from sub-
clinical infection to severe potentially lethal multi-system illness with jaundice and renal
failure [60, 47]. There are several laboratory tests available for diagnosis of leptospirosis,
but their sensitivity and specificity values are low and their usefulness are still under
discussion [20, 60]. Therefore, managing patients suspected of leptospirosis is a difficult
and important problem for the physicians. In addition, early diagnosis of leptospirosis is
essential because antibiotic therapy provides greatest benefit in early and severe stage of
leptospirosis. Potentially, doxycycline is the best option of antibiotic in initial treatment
while data of its efficacy against leptospirosis is limited [14, 47].
In cattle, control programs are usually more common than treatments. Three possi-
ble control programs are available: antibiotic therapy, environmental management, and
vaccination. Since antibiotic therapy is relatively expensive, it is not a commonly used
program. Even though environmental management could be an effective method to eliminate
the pathogen in the environment and prevent the propagation of leptospirosis, it is not
applicable for many cattle ranches due to their sizes. Vaccination is the cheapest and the
most common control method reducing the incidence of leptospirosis. However, its efficacy
varies across countries [40, 37, 52]. It has been reported some certain types of vaccines reduce
the incidence of infection and the duration and intensity of urine shedding in some countries
[7, 10, 52]. Implementation of vaccine strategies may vary depending on the size of farm and
the management strategy. For instance, some ranch managers gather all their cattle once or
twice a year in order to apply vaccination to all of their cattle at the same time. These kinds




We have formulated two projects for leptospirosis. The first part involves age structured
models of leptospirosis with impulse actions in cattle. While cattle are one of the most
sensitive species for leptospirosis, which creates drastic economical loss for the livestock
industries, there is not a mathematical model representing the dynamics of leptospirosis in
a cattle ranch. Two studies [46, 53] include livestock in their models using a continuous
vaccination policy, but most ranch managers apply vaccination with impulse actions. Thus,
we have built mathematical models illustrating the epidemiological dynamics of leptospirosis
in a cattle ranch with and without control programs.
We have built the models according to a typical ranch where the managers gather all their
cattle to apply vaccination and recruit some cattle at a specific time. We aim to understand
the behavior of leptospirosis and determine preventative actions in the cattle ranch. We start
with a preliminary age structure SIR model with DEs by excluding preventative actions
against leptospirosis to explore the propagation of leptospirosis. We have analyzed the
stability of the Disease Free equilibrium (DFE) by using the threshold quantities, basic
reproduction and target reproduction numbers, and found the effort required to control
leptospirosis. Then, we modified the preliminary model to represent the typical ranch to see
the effect of actions of the ranch managers to control leptospirosis. Therefore, we improved
the preliminary model with some vaccination and recruitment control programs in the form
of impulse actions to prevent the propagation of the disease. This system of ordinary
differential equations with impulse actions determines a schedule of control programs to
eradicate leptospirosis in the ranch.
The preliminary model indicates that leptospirosis spreads in the ranch without control
programs, and thus a control program is required to prevent the propagation of leptospirosis
in the ranch. The model with impulse actions suggests the application of control programs
once a year drastically reduces the number of infected cattle and corresponding deaths,
however, leptospirosis cannot be eradicated from the ranch and death due to the disease
always occurs when having impulse actions once a year. On the other hand, the application
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of control programs twice a year eradicates leptospirosis from the ranch after a sufficiently
long time.
The second part is a mathematical model for cost-effectiveness analysis and early
detection of leptospirosis in humans. Antibiotic treatment is supposed to be effective in
the course of manifestations towards lower mortality and morbidity when treatment is
started in the early acute phase, so diagnosis of leptospirosis in the early stage is essential.
However, there is not a mathematical model focusing on early detection of leptospirosis.
Suputtamongkol and his co-workers et at. [60] presented a study investigating the benefits of
diagnostic tests versus empirical treatment with a broad spectrum antibiotic for the patients
presenting at the hospital with complaints compatible with leptospirosis, but early detection
of leptospirosis is not included in their study. Thus, we developed a mathematical model to
compare treatment strategies and determine an optimal strategy that maximizes the number
of early detected patients and minimizes the corresponding costs for the patients suspected
of leptospirosis with some symptoms.
Imagine that the patients show up at a hospital with some symptoms, we know whether
these symptoms are severe or mild symptoms and how long they have these symptoms.
However, we do not know whether the cases are leptospirosis or non-leptospirosis and the
patients with mild symptoms will developed severe symptoms or not. The goal is to choose
one of six treatment strategies to minimize the corresponding costs and also to maximize
the number of early detected leptospirosis case.
We have developed a stochastic processing model with a computational algorithm to
achieve the goal. We start with identifying the patients according to their features. There
are four features of each patient: late/early case, severe/mild symptoms, leptospirosis /non-
leptospirosis and severe/mild pathway. Two of these features are known for each patient,
whether they are a late or early case and they have severe or mild symptoms. The other
two features are unknown, whether they have leptospirosis or not and they are on severe or
mild pathway. We have classified the patients according to their known features and found
treatment strategies for each of these classes separately. To identify the other features of the
patients we use the random numbers drawn from an uniform distribution, the probability of
being leptospirosis and the conditional probability of leptospirosis /non-leptospirosis patients
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developing severe symptoms. Eventually we generate tables consisting of the patients with
their features and we calculate the corresponding costs with these tables for each choice of
the physician for each class separately.
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Chapter 2
Leptospirosis in a cattle ranch
2.1 Introduction
Leptospirosis is a worldwide zoonotic disease. In tropical regions having favorable conditions,
such as temperature and higher humidity level, for the pathogen to survive for long
time periods, leptospirosis became endemic. Large outbreaks of leptospirosis happened in
Nicaragua, India Brazil, southeast Asia and the United States. The outbreaks of leptospirosis
occur with severe flooding due to increasing contact with contaminated water as in Central
and South America [36, 40]. Humans and a wide range of animals, such as domestic animals,
and rodents, are at risk. One estimate indicated that the overall prevalence of leptospirosis
in U.S. cattle is 35-50% [22]. Another study showed 42% of beef and 57% of dairy herds in
the United States are carrying the pathogen causing infection in 2003 and 2007 [50].
The pathogen causing the infection is Leptospira which is a pathogenic spirochaete
bacteria. The genus Leptospira involves pathogenic and non-pathogenic species. Nearly 250
serovars were recognized among the pathogenic Leptospira species. Antigenically, serovars
are categorized into serogroups, of which twenty-six have been described as pathogenic
strains. Leptospires colonize in the proximal renal tubules of various mammals, and
eventually they are excreted in the urine of carrier animals [37, 36].
Transmission of leptospirosis can occur through direct contact with infected animals
or through indirect contact with water and soil which has been contaminated by infected
animals. There are many factors playing a role in the transmission, for instance, climate,
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temperature and contact rate with reservoir hosts. While the main reservoirs are small
mammals such as rodents and rats, domestic animals such as dairy cattle are also well hosts
[52, 36].
Leptospirosis is one of the most serious diseases in cattle for the livestock industry. Cattle
can get infected at any age and the consequences of infection vary with age. The main
consequences of leptospirosis in juvenile cattle are a lower growth rate and higher disease
mortality rate than normal rates. However, the increased rate of abortion is the biggest
issue in adult cattle since one of the most common Leptospira serovar, hardjo, can remain
and reproduce in the reproductive tract of infected cattle for a long time. The bacteria
remaining in the reproductive tract cause vertical transmission of the disease to newborn
calves and increased rate of abortion. In addition, the infected cattle colonize the bacteria
in their kidneys which leads to bacterial shedding and increases the transmission of disease
[22, 50].
Leptospirosis has been reported as one of major causes of reproductive failure in cattle.
In Northern Ireland, the hardjo strain was recognized as the reason for nearly half of all
bovine abortions. Moreover, leptospirosis causes weak or apparently healthy, but infected
newborns [22]. Leptospirosis is also one of causes of milk reduction in cows [50]. In addition,
the infected cattle are a source of infection for humans due to Leptospira in their urine. All
these create significant economic loss for the livestock industry and society. Nevertheless,
in spite of its importance, leptospirosis is neglected due to challenges like the lack of the
epidemiological knowledge and prophylaxis, especially in tropical regions [37, 10, 40].
However, there are some control methods currently available. Three feasible control
programs available are: antibiotic therapy, environmental management, and vaccination.
The programs may not eradicate the causative agent in a herd, but they can significantly
reduce economic loss. Antibiotic therapy reduces reproductive problems, bacterial shedding
and the transmission of leptospirosis, but its application in the livestock is relatively
expensive. Environmental management programs can be effective as well in reducing the
incidence of leptospirosis in the herd especially during rainy periods. The implementation
of crucial environmental measures for long-term eradication of leptospirosis are hygiene
programs, reducing co-grazing, quarantine and isolation of infected animals [40]. Vaccination
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is the cheapest control method reducing the incidence of leptospirosis, however, its efficacy
varies across countries [40, 37, 52]. Variation in efficacy of hardjo vaccines may be related to
several factors, such as the formulation of vaccine, the challenge strain, and the climate of
the region. Vaccines containing the hardjo serovar or in combination with serovar pomona
have been reported to reduce the incidence of infection and the duration and intensity of
urine shedding in some countries [7, 10, 52]. Since vaccination provides temporary immunity
[68, 67], vaccinations should be repeated as needed. But, the desired vaccination schedule
and its efficacy are still under discussion. In general, vaccination reduces the incidence of
infection and the rates of abortion in healthy animals.
There are different types of environments in the livestock industry, e.g., stables, pastures
farms, and ranches. Some of them have facilities in which the managers can monitor
their livestock and control the outbreak of a possible disease by periodically cleaning the
environment. However, most livestock operations cannot control their facilities through
cleaning. In most cattle ranches, juvenile and adult cattle live together in pastures, thus it
is quite hard monitor the cattle in order to control the outbreak of a possible disease and
to prevent the propagation of infection. In general, the ranch managers gather all cattle
at certain times to give them necessary care, such as vaccination and anti-tick and anti-lice
baths. If the number of cattle is below a desirable size, the ranch managers bring new adult
cattle into the ranch for business purposes. These sort of ranches serve dairy and meat
production.
Many studies have discussed the severity of leptospirosis and possible intervention
methods in human and animals, however, not many mathematical models have been proposed
to analyze the epidemiology of leptospirosis and determine strategies to eradicate this disease.
In two studies, Khan et al. [31, 29] built models with system of ordinary differential
equations (ODEs) by considering the transmission of leptospirosis between human and vector
populations and analyzed the local and global stability of the endemic equilibrium and the
disease free-equilibrium. In a system of ODEs, Baca et al.[12] studied the stability and
intervention techniques for leptospirosis in human and animal populations. His model is one
of few models taking into account Leptospira living in the environment and the transmission
of disease through the bacteria. However, his model does not have a control method.
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Similarly, some other work developed models with ODEs by considering the transmission
of leptospirosis between human and rodent populations [66, 28, 49, 26]. Several studies of
ODEs used optimal control theory to choose management strategies in human and general
vector populations [46, 53, 30, 32]. In two of these [46, 53] the vector population is specified to
be livestock and their controls are hygiene, vaccination and some treatment programs. Their
models use a continuous vaccination policy, however, most ranch managers apply vaccination
at a specific time. Another recently released study developed ODEs for leptospirosis for
rotating populations of lambs [3]. The model consists of susceptible and infected lambs with
one population rotating out and another population coming in once a year, and includes
bacteria living in the environment. Their model predicts the conditions in which the infection
persists. Consequently, there is not a mathematical model that analyzes the epidemiology of
leptospirosis specifically focusing on cattle, even though cattle are one of the most sensitive
species for leptospirosis, which creates drastic economical loss for the livestock industries.
Therefore there is a need for a mathematical model representing the events in a cattle ranch
and illustrating the epidemiological dynamics of leptospirosis.
The purpose of our study is to understand the epidemiological behavior of leptospirosis
and offer some possible intervention strategies to reduce the loss for cattle ranchers.
Therefore, two mathematical models of leptospirosis with system of ODEs are proposed
to achieve the goal. Initially, a preliminary model is developed in the next section for a
ranch scenario, without vaccination. Our intention with this model is to illustrate the main
factors of the propagation of leptospirosis and observe the consequences without vaccination
in the system. Thus, the stability analysis is studied using the basic reproduction number
R0. In addition, some possible control measures are discussed by using target reproduction
numbers. Then, another model with impulse actions is introduced representing the actions
on a typical ranch. Vaccination and cattle replacement are implemented as the impulse
actions to examine their effect and to compare schedules of impulse actions. The numerical
results of models are shown for the model without vaccination and the model with impulse
actions. Some sensitivity analysis will be shown in Section 2.5. Finally our conclusions will
be discussed in Section 2.6.
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2.2 The preliminary model
In order to analyze the spread of leptospirosis in a cattle ranch, a preliminary epidemiological
model of leptospirosis without vaccination is proposed. Using a system of ODEs, the model
is based on a cattle ranch in which adult and juvenile cattle live in the same environment.
2.2.1 Formulation of preliminary model
As discussed in the introduction, the transmission rates of leptospirosis and its consequences
differs between adult and juvenile cattle, therefore the cattle are classified into two main age
classes, juvenile and adult, in the model. Each age class is split into three compartments
according to their infection status; susceptible juveniles SJ , infected juveniles IJ , and
recovered juveniles RJ , susceptible adults SA, infected adults IA, and recovered adults RA.
The unit of these cattle compartments is the number of cattle. In addition to the cattle
compartments, due to bacterial shedding from infected cattle, there is a compartment of
bacteria B living free in the environment. The unit of this bacteria compartment is 1010
Leptospires [12]. The cattle move from one compartment to another according to their age











Figure 2.1: Flow diagram of the transition of leptospirosis among the compartments for
the preliminary model.
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Regarding the ranch scenario and transition of cattle among the compartments, a
mathematical model is formulated by DEs as following.
dSJ
dt
= b(SA + (1− q)IA +RA)− SJ(m+ µJ)− SJ
(






= (1− σ)qbIA + SJ
(




− IJ(γJ + µIJ + µJ)
dRJ
dt
= γJIJ −RJ(m+ µJ)
dSA
dt
= Λ +mSJ − µASA − SA
(













− IA(γA + µIA + µA)
dRA
dt
= γAIA +mRJ − µARA
dB
dt
= θJIJ + θAIA − kB
The time unit in the differential equations is one day, therefore, the right hand side of
the system (2.1) represents the rate of change per day. As shown in Figure 2.1, the
cattle move from the susceptible compartments to the corresponding infected compartments
due to transmission from infected cattle or the bacteria in the environment. The cattle
move from the infected compartments to the recovered compartments due to their natural
recovery. The cattle make a transition from the juvenile class to the adult class due to age
progression. However, since the duration of the disease is short the infected juvenile cattle
does not make transition to the adult class. The infected cattle shed the bacteria into the
environment, therefore the amount of bacteria in the environment increases as the infected
cattle population increases. The amount of bacteria decays over time in the environment at
a rate k. The ranch managers bring some susceptible cattle into the ranch regularly to keep
the population constant, and this is approximated by a constant rate Λ. The rate of juvenile
and adult cattle leaving the ranch µJ , µA, and birth rate adult cattle b are taken into account
in the model, in addition to that, the death rates due to the disease µIA , µIJ are considered
because leptospirosis has a severe mortality rate. Since the reproductive failure is one of the
main results of leptospirosis, abortion and vertical transmission of the disease in newborn
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calves from the infected cattle are taken into account by putting some weight factors on the
birth rate of infected cattle. The parameters in this model are described below.
The force of infection from the susceptible juvenile compartment to the infected juvenile
compartment given by




This λJ represents the rate of susceptible juvenile cattle getting infected by contacting
infected cattle or the bacteria in one day.
βJJ := Transmission rate of the disease among juvenile cattle, with units of
1
day·cattle
βJA := Transmission rate of the disease from adult cattle to juvenile cattle, with units
of 1
day·cattle
βJ := Infection rate of juvenile cattle due to contact with the bacteria, with units of
1
day
The force of infection from the susceptible adult compartment to the infected adult
compartment given by




This λA represents the rate of susceptible adult cattle getting infected by contacting infected
cattle or the bacteria in one day.
βAA := Transmission rate of the disease among adult cattle, with units of
1
day·cattle
βAJ := Transmission rate of the disease from juvenile cattle to adult cattle, with units
of 1
day·cattle
βA := Infection rate of adult cattle due to contact with the bacteria, with units of
1
day
The rest of the parameters are described below
• K := Half saturation constant on the infection rate of the bacteria with unit of bacteria.
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• Λ := Recruitment rate of susceptible adult cattle with units of cattle
day
. The value of Λ
represents the number of susceptible cattle added into system in one day.
• m := Age transit rate of juvenile cattle, with units of 1
day
.
• γJ := Recovery rate due to natural immune response in juvenile cattle with units of
1
day
. The value of γJ represents the rate of infected juvenile cattle becoming recovered
by their natural immune response in one day.
• γA := Recovery rate due to natural immune response in adult cattle with units of 1day .
The value of γA represents the rate of infected adult cattle becoming recovered by their
natural immune response in one day.
• θJ := Amount of the bacterial shedding from an infected juvenile cattle with units of
bacteria
day·cattle . The value of θJ represents the unit of bacteria shedded into the environment
by an infected juvenile cattle in one day.
• θA := Amount of the bacterial shedding from an infected adult cattle with units of
bacteria
day·cattle . The value of θA represents the unit of bacteria shedded into the environment
by an infected adult cattle in one day.
• b := Birth rate of healthy adult cows with units of 1
day
. The value of b represents the
rate of healthy cow giving birth in one day.
• µJ := Rate of juvenile cattle leaving the ranch with units of 1day . The value of µJ
represents the rate of juvenile cattle leaving the ranch due to the natural death or
some other reason in one day.
• µA := Rate of adult cattle leaving the ranch with units of 1day . The value of µA
represents the rate of adult cattle leaving the ranch due to the natural death or some
other reason in one day.
• q := Disease vertical transmission rate, which is unitless. The value of q represents the
rate of calves born with infection from an infected adult cow.
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• σ := Abortion rate of an infected adult cattle, which is unitless. The value of σ
represents the rate of calves born dead from an infected adult cow.
• µIJ := Death rate due to the disease in infected juvenile cattle with units of 1day . The
value of µIJ represents the rate of infected juvenile cattle dying due to the disease in
one day.
• µIA := Death rate due to the disease in infected adult cattle, with units of 1day . The
value of µIA represents the rate of infected adult cattle dying due to the disease in one
day.
• k := Decay rate of the bacteria with units of 1
day
.
2.2.2 Stability analysis of the disease free equilibirum
One of the main concept of mathematical modelling for epidemiological study is to investigate
the disease free equilibrium (DFE) and the stability of DFE. [27, 8, 17]. This subsection
concentrates on the existence of a DFE and necessary conditions for the stability of DFE.
The disease free is an equilibrium point where disease does not exist and the entire
population is susceptible. Therefore,
X∗ = (I∗J , I
∗
A, B










A, 0, 0) (2.2)
is the form of the DFE for the system (2.1). The first step is to examine the existence of
a DFE. In order to find a DFE, the right hand side of system (2.1) is set to zero at the
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equilibrium point given in (2.2):
dSJ
dt



















By doing some algebra, an equilibrium
S∗J =
Λb



















A) = (0, 0, 0,
Λb
(m+ µJ)µA − bm
,
Λ(m+ µJ)
(m+ µJ)µA − bm
, 0, 0) (2.3)
is an equilibrium point. However, a DFE must be biological feasible, which means SJ , SA > 0.
If we assume that Λ, b,m+ µJ are positive and (m+ µJ)µA − bm > 0, then the equilibrium
point in (2.3) is the DFE for the system (2.1). Notice that the DFE is uniquely identified for
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a given set of parameter values. The biological interpretation of those assumptions are that
the ranch managers must import some susceptible cattle and there must be the following







After ensuring that the DFE exists for the system (2.1) under the assumptions, the stability
of DFE has to be checked. To check the stability of (2.3), the Next Generation Matrix
(NGM) method is used. The method provides simplicity by considering only the infected
classes in the calculation [5, 18, 63, 64]. The procedure of NGM method is described as
following:
~x′ = F − V
x′i = fi(x) = Fi(x)− Vi(x) = Fi(x)− (V −i (x)− V +i (x)), i = 1, ..., 7
where ~x = (IJ , IA, B, SJ , SA, RJ , RA) and
• Fi(x):= Rate of appearance of new infections in compartment i
• V +i (x):=Rate of transfer of individuals into compartment i by all other means
• V −i (x):= Rate of transfer of individuals out of compartment i by all other means.
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Hence, F and V are calculated for the system of (2.1):
F =













IJ(γJ + µIJ + µJ)
IA(γA + µA + µIA)
kB
−b(SA + (1− q)IA +RA) + SJ(m+ µJ) + SJλJ(t)
−Λ−mSJ + µASA + SAλA(t)
−γJIJ +RJ(m+ µJ)
−γAIA −mRJ + µARA

.
Notice that we assume the bacteria is an infected class and the shedding term is a new
infection and recall
λJ(t) = βJJIJ + βJAIA +
βJB
K +B
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0 γA + µIA + µA 0
0 0 k












































The each entry of NGM kij represents the expected number of new cases arise in a fully
susceptible population by an infected individual of type j among the susceptible individuals
of type i [55]. The spectral radius of NGM is called the basic reproduction number R0 which
is the average number of secondary cases arising in the the entirely susceptible population
[18], i.e. ,
ρ(FV−1) = max {λ1, λ2, λ3} = R0
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where λi are the eigenvalues of NGM given in (2.4). The value of R0 determines the stability
of DFE. The DFE in (2.3) is locally stable if and only if R0 < 1 [63, 18]. The quantity of
R0 is a measure of the disease propagation, and the explicit format of R0 gives intuition to
know the potential impact of various parameters. However, the explicit format of R0 is very
complicated and hard to interpret for the NGM given in (2.4), but the numerical value of
R0 can be calculated with a given set of parameter values.
2.2.3 Repoduction numbers of the preliminary model
Although the basic reproduction number R0 can be interpreted as a control measurement to
prevent the propagation of a disease for a homogeneous host population, this interpretation
may not be valid for a heterogeneous host population [25]. Therefore, some other definitions
of control measurements are needed to be used for heterogeneous host types. One definition
of control measurements for the heterogeneous host types is the type-reproduction number.
This definition can play the role of R0 when the propagation of the disease can be prevented
by targeting a subset of the population, instead of the whole population [25]. For instance, a
disease control strategy might be an application of vaccination to reduce the susceptibility of
a particular host type rather than the whole population, then the type-reproduction number
can inform us whether the propagation of the disease can be controlled with this vaccination
strategy. If so, how much effort is required to eradicate the disease. The definition of type-
reproduction number is only useful when the control strategy is the reduction of susceptibility
of a particular host type or the reduction of infectiousness of a particular host type. Thus,
another analogous definition of the type-reproduction number, the target reproduction
number TS, is to be used for the control measurement to prevent the propagation of a
disease by targeting multiple host types or vectors causing the disease propagation for the
heterogeneous host populations [55]. The definition of target reproduction number is more
general than the type-reproduction number. For instance, we may want to control the
propagation of the disease by reducing the infectiousness of multiple vector types rather
than the susceptibility of a particular host type.
Before giving the definition of target reproduction number, we want to give a motivation.
Recall that each entry of a NGM represents the transmission of the disease from one
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an entry kij of K is the expected number of new cases due to an infected individual of type j
causing the infection of type i among fully susceptible individuals of type i [55, 25]. Thereby,






: The expected number of new cases arise in the susceptible juvenile




: The expected number of new cases arise in the susceptible juvenile






: The expected number of new cases arise from the susceptible juvenile






: The expected number of new cases arise in the susceptible adult






: The expected number of new cases arise in the susceptible adult






: The expected number of new cases arise in the susceptible adult
compartment due to the bacteria compartment.
• k31 = θJγJ+µIJ+µJ : The expected amount of the bacteria contributed by one individual
in the infected juvenile compartment.
• k32 = θAγA+µIA+µA : The expected amount of the bacteria contributed by one individual
in the infected adult compartment.
The following figure shows how the transmission of the disease moves among the juvenile












The transmission of the disease occurs from a generation to the next generation by kij.
If one can reduce the infectiousness of a infected compartment, then the transmission of
the diseases between this infected compartment and all other susceptible compartments will
diminish. Thus, the all entries of a column of K will diminish. Similarly, if one can reduce
the susceptibility of a susceptible compartment meaning that reducing the possibility of a
susceptible individual getting infected, then the transmission of the disease between this
susceptible compartment and the infected compartments will decrease. Thus, the all entries
of a row of K will decrease. According to this intuition, the target reproduction number is
defined by,
TS = ρ(KS(I −K +KS)−1)
where K is the corresponding Next Generation Matrix, I is the identity matrix and KS is
the matrix consist of targeted entries in the NGM [55]. For instance, If the propagation of
the disease can be controlled by reducing a set of entries in the NGM, then KS is the matrix
of this set of entries and zeros. To define the target reproduction number, an inequality of
ρ(K −KS) < 1 is required. If the inequality of ρ(K −KS) < 1 fails, then the propagation
of disease cannot be controlled by targeting these entries of the NGM. There are two useful
results for the target reproduction number: First, TS < 1 if and only if R0 < 1 [55]. The
24




meaning that each entry of the targeted set is multiplied by quantity 1TS , then the disease
free equilibrium is locally stable. Note that quantity will always between 0 and 1 as long as
TS > 1 which means the DFE is not stable and effort is required to eradicate the disease. We
say the disease can be controlled as long as the quantity of effort given in (2.5) is implemented
[55]. If the set of targeted entries is all the entries of a row of the NGM, then the target
reproduction number turns out to be the type-reproduction number which is given
Ti = eTi K(I −K +KS)−1ei (2.6)
where i the index of targeted row and ei represents i the unit vector. Note that we show
that Ti is a positive number in the appendix.
A target reproduction number can be defined for the NGM given in (2.4) in order to
find the effort required to eradicate the disease and the control measurement TS for the
stability of DFE. Imagine that the propagation of the disease can be controlled by reducing
the susceptibility of adult cattle compartment, such as applying vaccination to the adult






















If we assume (2.7) holds, the target reproduction number can be defined. By using the
formula given in (2.6),
TS =
(k11 − 1)(k23k32 + k22) + k13(k22k31 − k21k32)− k12(k23k31 + k21)
k31k13 + k11 − 1
.
Note that TS is the measure of the disease propagation with same threshold asR0. Therefore,
if TS < 1 then the DFE is locally stable. Note finding an explicit form of the target
reproduction number is easier than R0.
Another consequence of the target reproduction number is that if the susceptibility of
adult cattle compartment which means the second row entries of NGM given in (2.4) can be




(k11 − 1)(k23k32 + k22) + k13(k22k31 − k21k32)− k12(k23k31 + k21)− k31k13 − k11 + 1
(k11 − 1)(k23k32 + k22) + k13(k22k31 − k21k32)− k12(k23k31 + k21)
then the DFE is stable and the disease dies out.
2.2.4 Parameter selection
In this section, the parameters used in the model (2.1) are chosen according to the events
happening in the ranch and some biological facts. We assume that 300 cattle can occupy the
ranch, and 70 of those are juvenile. The ranch managers aim to maintain the distribution
of population while they approximately sell 70 adult cattle every year for their business
purposes. They adjust the birth rate of healthy cattle b and the rate of adult cattle leaving
the ranch µA to achieve their goal. We constructed a model with ODEs to find the best
estimation of b and µA that serves the rancher goals while ignoring all other external factors
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where NJ , NA are total number of juvenile and adult cattle. We assume the rate of juvenile
cattle leaving the ranch is µJ =
1
43×365 as in Silva et al. [58]. The duration of newborns
staying in the juvenile class is 14 months, so the age transition rate of juvenile cattle is
approximately m = 1
420
. We run this model for one year with values and estimate µA, b that
best serve the rancher goals which is to get 70 newborns every year and let 70 adult cattle
out of the ranch. So the b, µA that
• b = 1
3.5×365
• µA = 13.5×365
There are approximately 65 newborns and 70 adult cattle leaving the ranch at the end of year
with this set of parameters. This is a bit below the rancher goal, however, there are some
other facts preventing us to change the parameters more such as maturation rate. Figure
2.2 shows the dynamic of juvenile and adult populations.
Figure 2.2: Total number of juvenile and adult cattle during one year with initial condition
NJ(0) = 70, NA(0) = 230
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Some parameters used in the model (2.1) can be chosen based on biological facts.
• θJ : If a unit of bacteria is 1010 Leptospires, there are 10 units of bacteria in one liter
cattle urine [12]. Most bacteria cannot survive or be effective in the transmission of
disease after being shed [3]. If we assume 0.01% of these bacteria survive, the bacteria
contributing to the transmission of the disease when an infected cattle urinate one
litter is 0.001 units of bacteria. If we assume each juvenile cattle produces 7 liters of
urine in a day, then θJ = 0.007 [65].
• θA : Similarly, if we assume each adult cattle produces 14 liters of urine in a day, then
θA = 0.014 [65].
• k : The bacteria can survive in the environment from two weeks to several months




• σ : There are not many resources discussing the value of an abortion rate of
leptospirosis which is the proportion of pregnant leptospirosis cows making abortion
due to leptospirosis. Some agricultural extension publications state that the abortion
rate of leptospirosis can be up to 30 percent [1]. Silva et al. [57] mentions 3 cases of
abortion in 38 infected cattle by leptospirosis. We assume σ = 0.0789 by dividing 3 by
38.
• q : We have not found any resources about the vertical transmission rate. An
experiment by Zimmerman at al. [67] indicates 5 of 18 infected cattle had positive
results of bacteriologic culture of reproductive reproductive system tissue. By relying
on some expert opinions, we assume q = 0.27.
• γJ : The duration in the infected compartments equals the duration of bacterial
shedding. An experiment by Leonard et al. [35] indicates a group of naturally infected
heifers, juvenile cattle, shed Leptospires for between 28 and 40 weeks, and a group of
experimentally infected heifers shed Leptospires for between 8 to 60 weeks [35]. We
choose a point close to the mean of the numbers between 8 and 60. Therefore we





• γA : We assume the duration of bacterial shedding in adult cattle is twice as long as







• µIA : We use the rate from a mathematical model for leptospirosis in cattle by Sadiq




• µIJ : We have not found any resources about disease death rate for juvenile. Since




• Λ : We assume the recruitment rate is 2
365
to make R0 reasonable.
Next we estimate the transmission rates, βJJ , βJA, βAA, βAJ , βJ , βA and K, the half saturation
constant. They are the most challenging parameters to estimate since many factors impact
their values such as the disease type, environmental condition, and contact rates. Before
starting their estimations we assume a relationship among the transmission rates because
of some disease background such as adult cattle get infected and transmit the disease at a
higher rate than juvenile cattle [23]
βAJ = βAA = βJA = 2× βJJ and βA = 2× βJ (2.8)
With the relationship given in (2.8), we estimate the transmission rates and half saturation
constant by assuming the prevalence of leptospirosis being 35% in the preliminary model
between 200 and 365 days. We have run the preliminary model for one year and found the
best fit of transmission rates and half saturation constant for 35% prevalence between 200
and 365 days. The best fit of the transmission rates and half saturation constant are
• βJJ = 5× 10−5
• βJA = 10−4
• βJ = 6× 10−4
• βAA = 10−4
• βAJ = 10−4
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• βA = 12× 10−4
• K = 34
The entire list of parameters used this study given in Table 2.1
2.3 Model with impulse actions
The next model that serves our main goal is built according to real events happening in a
ranch. We assume that juvenile and adult cattle live in a ranch and the ranch managers
gather their cattle at a certain time to give them necessary care such as vaccination. In
addition, the ranch managers want to keep a certain amount of cattle in the ranch for their
business purposes if possible. Thus, they bring some adult cattle into the ranch at the time of
gathering if the current number of cattle is below the desirable size. All these events happen
at once, therefore a mathematical model consist of DEs and impulse actions of vaccination
and replacement is developed to imitate the dynamic in the ranch. The purpose of this model
is to see whether the number of application of vaccination in a year is enough to eradicate
the disease or reduce the loss for the ranchers.
Table 2.1: The parameters with their description
Parameter Description Value
b Birth rate of newborns from healthy adult cattle 7.8278× 10−4
µJ Rate of juvenile cattle leaving ranch 6.3715× 10−5
µA Rate of adult cattle leaving ranch 7.8278× 10−4
m Age transition rate of juvenile cattle 2.4× 10−3
θJ Amount of bacterial shedding from an infected juvenile cattle 7× 10−3
θA Amount of bacterial shedding from an infected adult cattle 1.4× 10−2
K Half saturation constant on transmission rate due to contact with bacteria 34
k Decay rate of the bacteria 1.1× 10−2
σ Abortion rate of infected adult cattle 0.0789
q Vertical transmission rate from infected cattle 0.27
γJ Recovery rate due to natural immune response in juvenile cattle 5.5× 10−3
γA Recovery rate due to natural immune response in adult cattle 2.7× 10−3
µIJ Death rate due to disease in infected juvenile class 3.3× 10−2
µIA Death rate due to disease in infected adult class 6.7× 10−3
βJJ Transmission rate of disease among juvenile cattle 5× 10−5
βJA Transmission rate of disease from adult cattle to juvenile cattle 10
−4
βJ Infection rate of juvenile cattle due to contact with bacteria 6× 10−4
βAA Transmission rate of disease among adult cattle 10
−4
βAJ Transmission rate of disease from juvenile cattle to adult cattle 10
−4
βA Infection rate of adult cattle due to contact with bacteria 12× 10−4
Λ Recruitment rate of susceptible adult cattle 5.5× 10−3
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2.3.1 Formulation of model with impulse actions
Before introducing the model with impulse actions, we want to point some facts about
vaccination on which the model is based. Vaccination reduces the incidence of infection, the
reproductive failure, the duration and intensity of urine shedding, however, its efficacy is
temporary [68, 67, 7, 1]. Therefore, we assume that the level of immunity from vaccination
increases gradually right after the application of vaccination until it reaches a maximum
level, then it stays at that level for a while and then it gradually decreases until it hits
the minimum level. The vaccination only provides the immunity to the susceptible cattle
[23]. The susceptible cattle that are vaccinated are called “vaccinated susceptible cattle”.
However, the vaccination is not perfectly protective, so some of the vaccinated susceptible
cattle can get infected while they are in a vaccinated [52, 7, 67, 54, 23]. These infected
cattle are called “vaccinated infected cattle”, and they are not same as the cattle that were
infected before the application of vaccination. We assume these vaccinated infected cattle
shed less bacteria compared to the infected cattle that were infected before the application
of vaccination and they colonize less bacteria in their kidney and reproductive track [67, 50].
Thus, they do not have an serious issue of reproductive failure. Therefore, their abortion and
vertical transmission rate are lower than the infected adult cattle that are infected before the
application of vaccination. Since the vaccination does not affect the cattle that were infected
before the application of vaccination, we assume the application of vaccination does not make
any change in the bacterial shedding and the reproductive failure of these infected cattle [23].
The recovered cattle can get infected with a different strain of leptospirosis. Since we only
consider serovar hardjo strain, we assume that the recovered cattle will not get infected again
and the application of vaccination does not offer any advantage or disadvantage to them.
With all these assumptions, we construct the mathematical model with impulse actions
using the situation in the ranch. The model consist of two main parts. The first part is
the impulse actions that happen at the gathering time where all the cattle instantaneously
get vaccinated and replacement happens as discussed in the subsection 2.3.2. The second
part is the system of ODEs where the cattle make transitions among the compartments until
next gathering time as discussed in the subsection 2.3.3. Figure 2.3 illustrates the impulse
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actions and the system of ODEs. As Figure 2.3 shows the cattle make transition among the
compartments similar to the preliminary model discussed in the section 2.2. However, there
are four additional compartments: VSJ vaccinated susceptible juvenile cattle, VSA vaccinated
susceptible adult cattle, VIJ vaccinated infected juvenile cattle and VIA vaccinated infected
adult cattle compartments. The vaccinated susceptible cattle are less likely to be infected
compared to the susceptible cattle being infected. Therefore, there are additional rSJ , rSA
reduction factors on their transmission rate. The vaccinated infected cattle shed less bacteria
in their urine compared to the infected cattle, therefore there are rIJ , rIA reduction factors on
their bacterial shedding. All these reduction factors are 0 < rSJ , rSA, rIJ , rIA < 1. Note that
there are no vaccinated recovered cattle compartments because we assume the application of
vaccination does not make any change in their situation. Additional parts in Figure 2.3 are


















Figure 2.3: Flow diagram of the transition of cattle among the compartments with impulse
actions and ODEs
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2.3.2 The impulse actions
The first procedure of the model are the impulse actions. We assume that the ranch managers
apply instantaneously the vaccination to all the cattle in the ranch at the gathering time.
They want to keep N cattle in the ranch. If the number of cattle is dropped below N ,
they bring new susceptible cattle into the ranch at the time of gathering. Therefore a
mathematical representation of these impulse actions is as follows
































⇒ N(kT+) = N
we assume that N cattle are in the ranch at the beginning. T represents the length of time
between two gatherings time. Therefore T− is the time before impulse actions and T+ is the
time that after impulse actions. Since the impulse actions repeats over time, k represents
the index of impulse actions. The consequence of this impulse action is the susceptible cattle
move into vaccinated susceptible cattle compartment, the infected and recovered cattle stay
in their compartments at the end of gathering time. Since the ranchers want to keep N
cattle in the ranch, an additional term N −N(kT−) is added to the vaccinated susceptible
adult compartment. The consequence of the impulse actions is that there are N cattle in the
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ranch and all of them are vaccinated at T+ except that the infected, I and the recovered, R
cattle are not affected.
2.3.3 The system of ODEs
The second part of the model is a system of ODEs. Right after the impulse actions, a
system of DEs continue until the next impulse action. This system is a modification of the
preliminary model discussed in the section 2.2. There are four additional compartments
VSJ , VSA, VIJ , VIA and some reduction factors due to application of vaccination in the system
as discussed in the subsection 2.3.1. The description of the model is similar to the description
of the preliminary model given in (2.1), however, there are several additional parameters
and differences. Since vaccinated infected cattle colonize less bacteria in their reproductive
track, we assume the vertical transmission rate of the disease and abortion rate are smaller
in vaccinated infected adult cattle than in infected adult cattle. Therefore, there are
additional terms qV and σV in the model (2.10). Vaccinated susceptible juvenile cattle,
VSJ , make transition to vaccinated infected juvenile cattle, VIJ , compartment with a smaller
rate than the transmission rate between susceptible juvenile cattle and infected juvenile
cattle. Therefore, a reduction factor rSJ is multiply with the force of infection in order to
reduce the transmission rate between vaccinated susceptible juvenile cattle and vaccinated
infected juvenile cattle. Similarly, vaccinated susceptible adult cattle, VSA, make transition
to vaccinated infected adult cattle ,VIA, compartment with a smaller transmission rate than
the transmission rate between susceptible adult cattle and infected adult cattle. Therefore,
a reduction factor rSA is multiply the force of infection.
Note that rSJ , rSA are functions of time due to change in the vaccine efficacy. In
addition, vaccinated infected juvenile and adult cattle shed bacteria into the environment,
but they shed less bacteria compare to the infected juvenile and adult cattle. Therefore,
some additional reduction factors, as rIJ , rIA functions of time are multiply the bacterial
shedding of vaccinated infected juvenile and adult cattle. There are a few parameters and
functions needed to be chosen in the model (2.10).
34
• qV : Disease vertical transmission rate. The value of qV represents the rate of calves
born with infection from vaccinated infected adult cows. We assume that the vertical
transmission rate of vaccinated infected cows is half of vertical transmission rate of
infected cows, therefore qV = 0.135.
• σV : Abortion rate of vaccinated infected adult cows. The value of σ represents the rate
of calves born dead from vaccinated infected adult cows. We assume that the abortion
rate of vaccinated infected cows is half of infected cows, therefore σV = 0.0394.
dSJ
dt
= b(SA + (1− q)IA + (1− qV )VIA +RA + VSA)− SJ(m+ µJ)
− SJ
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= (1− σ)qbIA + (1− σV )qV bVIA + SJ
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− VIJ(µJ + µIJ + γJ)
dRJ
dt
= γJ(IJ + VIJ)−RJ(m+ µJ) (2.10)
dSA
dt
= mSJ − µASA − SA
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= mVSJ − µAVSA − VSA(1− rSA)
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− VIA(µA + µIA + γA)
dRA
dt
= γA(IA + VIA)− µARA +mRJ
dB
dt
= θJIJ + θJ(1− rIJ)VIJ + θAIA + θA(1− rIA)VIA − kB
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2.3.4 Reduction functions on the bacterial shedding and force of
infection
We assume the reduction factors rSJ(t), rSA(t), rIJ(t), rIA(t) are functions of time and their
values range over [0, 1]. The efficacy of vaccination is not at the maximum level right
after the application of vaccination, therefore, we assume the reduction functions are at a
minimum level at the time of the application of vaccination and increase until they reach
the maximum level. In addition, the efficacy of vaccination does not stay at the maximum
level for forever, therefore the reduction functions decrease after staying at the maximum
level for a while. In this study, we assume the reduction functions are piecewise linear. A





t+ rmin t ∈ [0, tH ]





t ∈ [tM , 365]
with
• rmax := The maximum level of reduction rate. This represents the highest rate of
reduction on the transmission rates due to vaccination.
• rmin := The minimum level of reduction rate. This represents the lowest rate of
reduction on the transmission rates due to vaccination.
• tH := The time that the reduction rate achieves the maximum level
• tM := The time that the reduction rate starts to decrease
In order for find reduction functions in the model (2.10), we need to estimate rmax, rmin, tH , tM
for each rSJ , rSA, rIJ , rIA. That means we need to know rmax, rmin, tH , tM in the reduction of
bacterial shedding and disease transmission for adult and juvenile cattle separately. Several
studies agree that the application of vaccination reduces the bacterial shedding and the
disease incidence [54, 7, 15, 52]. However there is not significant information for the reduction
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rate of the disease transmission and bacterial shedding in vaccinated cattle. We assume that
A study points out the efficacy of vaccination is higher in young cattle [54]. Another study
supports that vaccinated young cattle are less likely to become infected compare to vaccinated
adult cattle [23]. Based on these two studies [54, 23], we assume that the vaccination is 15%
less effective in the adult cattle than the juvenile cattle.
rIA = .85× rIJ and rSA = .85× rSJ (2.11)
A study concludes that the efficacy of vaccination is approximately 88.7% [54]. Therefore,
we choose rmax = 88.7 and assume rmin = .1 in the reduction functions on the transmission
rate of the disease for vaccinated susceptible juvenile cattle. With the assumption in (2.11)
rmax = 0.754 and rmin = 0.085 in the reduction function on the transmission rate of disease
for vaccinated susceptible adult cattle.
A study mentions Leptospires were detected in the urine of one vaccinated infected
heifer via Immunofluorescence assay at 3 time points, compare with infected heifer that
were Immunofluorescence assay positive for up to 5 time points [67]. Therefore, we assume
that the bacterial shedding rate is 40% less, rmax = 0.4 and the efficacy of vaccination drop to
0, rmin = 0 in vaccinated infected juvenile cattle. With the assumption in (2.11) rmax = 0.34
and rmin = 0 on the bacterial shedding rate of vaccinated infected adult cattle. Next we need
to adjust the time points tH , tM . For the sake of simplicity, we assume tH , tM values are same
in the reduction functions rSJ , rSA, rIJ , rIA. We have not found any resource informing us
about the durations that vaccination reaches the maximum level and stays at the maximum
level. However, there are some studies indicating vaccination provides a protection against
leptospirosis up to one year [7, 1]. Therefore, we assume the effectiveness of vaccination is
one year and we adjust tH , tM values according to the procedure of experiments. In three
experiments [7, 15, 52] two doses of vaccination are applied 3 or 16 weeks apart and heifers
were challenged 0 or 16 weeks after the application of vaccination. According to this we
assume the efficacy of vaccination reaches the maximum level in 30 days, tH = 30, and
stays at the maximum level during 240 days, tM = 240. Figure 2.4 shows the graphs of the
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reduction function on the bacterial shedding and the disease transmission of juvenile cattle
for impulse actions once a year.





t+ rmin t ∈ [0, tH ]







+ r∗min t ∈ (180, 180 + tH ]
rmax t ∈ [180 + tH , 365].
Note that a few animals will be newly vaccinated and those few animals will bring the
reduction down a little at that time. This change at a vaccination time is approximated
by r∗min, which is the proportion of newly vaccinated animals (out of the total number of
animals at time of vaccination) multiplied by rmax. Figure 2.5 shows the graphs of the
reduction functions on the bacterial shedding and on the disease transmission of juvenile
cattle for impulse actions twice a year.
Figure 2.4: The reduction functions on the bacterial shedding and the disease transmission
due to once a year vaccination
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Figure 2.5: The reduction functions on the bacterial shedding and the disease transmission
due to twice a year vaccination
2.4 Numerical results
2.4.1 The numerical results of preliminary model
The numerical simulations of the models are shown in this section to see the dynamical
behavior of the models with application of impulse actions and without application of
impulse actions. We start with simulating the preliminary model (2.1) for four years with the
parameters listed in Table 2.1 and the initial conditions given in Table 2.2. Figure 2.6 shows
the number of infected cattle during four years for the preliminary model. The number of
infected cattle increases fast in the first 250 days. This indicates the outbreak of the disease
occurs in the first two hundred fifty days. Note that the number of infected cattle in the
ranch reaches seventy in two hundred fifty days. This is a high number relative to a ranch
with 300 cattle. The number of new case decays to zero at the end of three years, however,
the total number of cattle is around 100 at the end of three years. To understand the severity
of the disease comprehensively, the number of death due to disease is calculated during four
years.
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Table 2.2: Initial conditions of the preliminary model
Susceptible Infected Recovered
Juvenile 70 0 0
Adult 225 5 0
Figure 2.6: The number of infected cattle in the ranch during four years for the preliminary
model
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Table 2.3 shows the total number of death due to disease for each year. As shown, the
total number of death due to disease is 150 four in the first year which is high for a ranch
occupying three hundred cattle. After three years, the number of death due to disease drop
to one. However, there are less than 100 cattle in the ranch after three years. To know
whether the ranch manager can maintain the structure of population without any actions
taking against leptospirosis, we plot the structure of population.
Figure 2.7 shows number of juvenile and adult cattle in the ranch during four years. The
number of adult cattle drop seventy and the number of juvenile cattle drop below twenty
in the middle of second year. The system reaches an equilibrium point, but with a low
number of cattle. There are approximately one hundred cattle in total in the ranch at that
equilibrium point. Therefore, the ranch manager cannot maintain the desirable structure of
population in the ranch without any preventative action. Recall that we discussed DFE, R0
and TS in section 2.2 for model (2.1). The numerical value of these quantities are calculated
with parameters given in Table (2.1)










A) = (0, 0, 0, 86, 268, 0, 0)
• R0 = 3.2195
• TS = 4.8343
As seen in the simulations the DFE is not stable and the control measurements R0 and TS
also confirms that the DFE is not stable since both quantities are greater than one. The other
conclusion of target reproduction number TS is the required effort to control the outbreak of
disease.
Table 2.3: The total number of deaths due to the disease during four years for the
preliminary model
Year(s) First Second Third Fourth
Deaths 154 54 6 1
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Figure 2.7: The number of juvenile and adult cattle in the ranch during four years for the
prelimary model
Recall that we said if the transmission of disease can be reduced by
1− 1
TS
then the DFE will be locally stable. Therefore, with the value of target reproduction number
found, the required effort is 1 − 1TS = 0.79 to eradicate the disease in the ranch. If a such
control program can reduce the rate of adult cattle getting infected by 79% then the disease
free equilibrium will be stable.
2.4.2 The numerical results of model with impulse actions once a
year
Next, we want to observe the numerical simulations of the model with impulse actions once
a year. The model has been run for four years with parameters listed in Table 2.1 and the
initial conditions given in Table 2.4.
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Juvenile 0 70 0 0 0
Adult 0 225 5 0 0
Figure 2.8 shows the number of infected cattle in the ranch during four years. As shown,
the number of infected cattle fluctuates between 5 and 12 during four years. However, the
number of infected cattle increases gradually in the long run. The application of impulse
actions reduces the number of infected cattle in the ranch, however, the applications once a
year cannot eradicate the disease in the ranch. The disease exists in the ranch and deaths
due to the disease occurs for long time.
Table 2.5 shows the number of death due to disease during four years. As seen, the
application of impulse actions does not only reduce the number of infected cattle, but also
the number of deaths due to disease. However, the number of deaths due to disease increases
gradually during four years. We also want to see the structure of population in the ranch
for the model with impulse actions once a year.
Figure 2.9 shows the number of juvenile and adult cattle in the ranch during four years
for the model with impulse actions once a year. The ranch managers may maintain the
desirable structure of populations with a lower juvenile size, however, they lose over twenty
cattle every year and the lost increases each year because the vertical gaps between impulse
actions shown in Figure 2.8 extends. Therefore, more impulse actions is required to save the
cattle.
2.4.3 The numerical results of model with impulse actions twice
a year
Finally, the model with impulse actions twice a year has been run for four years with
parameters listed in Table 2.1 and the initial conditions given in Table 2.4.
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Figure 2.8: The number of infected cattle in the rach during four years for the model with
impulse actions once a year
Table 2.5: The number of deaths due to the disease during four years for the model with
impulse actions once a year
Year(s) First Second Third Fourth
Deaths 14 22 28 29
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Figure 2.9: The number of juvenile and adult cattle in the ranch during four years for the
model with impulse actions once a year
Figure 2.10 shows the number of infected cattle in the ranch during four years with model
impulse actions twice a year. The number of infected cattle in the ranch decays gradually
with the application of impulse actions twice a year. Therefore, the disease can be controlled
with the applications twice a year.
Table 2.6 shows the number of death due to disease during four years. We observe that
none of the cattle die due to disease by the end of four years. In addition, the application of
impulse actions twice a year preserves the structure of population.
Figure 2.11 shows the number of juvenile and adult cattle in the ranch during four years.
As shown, the ranchers can maintain the structure of ranch as they want with the application
of impulse actions twice a year. They do not need to bring new cattle into ranch at the end of
four years because the vertical gaps between impulse actions shown in Figure 2.11 narrows.
Finally, Figure 2.12 shows the simulations of three models with respect to number of new
cases for 4 years.
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Figure 2.10: The number of infected cattle in the ranch during four years in the model
with impulse actions twice a year
Table 2.6: The number of deaths due to the disease during four years for the model with
impulse actions twice a year
Year(s) First Second Third Fourth
Deaths 10 7 3 2
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Figure 2.11: The number of juvenile and adult cattle in the ranch for the model with
impulse actions twice a year
Figure 2.12: The results of each model with respect to the number of infected cattle in the
ranch during four years
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2.5 Sensitivity analysis
A method of global sensitivity analysis, Latin Hypercube Sampling (LHS) and Partial Rank
Correlation Coefficients (PRCC), is performed to investigate the impact of the parameters
used in the model 2.10 on the total number of new infected cattle in the ranch. The input
variables are the parameters used in the model (2.10) and the output variable is total number
of new infected cattle during four years in the procedure of sensitivity analysis.
The input variables are sampled through LHS method which belongs to Monte Carlo
(MC) sampling method and achieves same accuracy with fewer samples compare to the
other sampling methods [38]. The method generates N by p LHS-matrix consisting of N
samples of each parameter drawn from a probability distribution function (pdf). Then the
model (2.10) is run with LHS-matrix to calculate N output variables.
To measure the correlation between input and output variables, PRCC is performed which
is a measure of correlation between residuals obtained from a regression of ranked input and
output variables. PRCC provides reliable results as long as a monotonic relationship exists
between input and output variables, not necessary linear relationsip [38].
To examine a monotonic relationship between input and output variables, a corresponding
input variable is sampled on a certain range N times and all other input variables are fixed
on some base line values, then the model is run with these input variables N times to get N
output variable, and then the relationship between each corresponding input variable and
output variable is observed. This process is repeated for each input variable.
To examine the monotonic relationship between the parameters and output variables of
the model (2.10), a sample of size 300 is generated for each parameter to run the model (2.10)
and total number of new infected cattle calculated in the model (2.10) during four years as
an output variables. Figures 2.13-2.15 show the monotonicity results of input versus output
variables for each parameter value. As shown a monotonic relationship holds between input
and output variables for each parameters, therefore, we can rely on LHS-PRCC method to
conclude a possible correlation between input and output variables.
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Figure 2.13: X-axis is the range of parameters b, µJ , µA, θJ , θA, K, k and Y-axis is total
number of new infected cattle in the ranch
Figure 2.14: X-axis is the range of parameters σ, σV , q, qV , γJ , γA, µIJ and Y-axis is total
number of new infected cattle in the ranch
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Figure 2.15: X-axis is the range of parameters µIA , βJJ , βJA, βJ , βAA, βAJ , βA and Y-axis is
total number of new infected cattle in the ranch
The value of parameters in the Table 2.1 are used as baseline values and the range of %50
above and below these baseline values are defined to sample the input variables. The input
variables are sampled 300 times in these ranges from a uniform pdf to form the LHS matrix.
The LHS matrix is used to run the model 2.10 for four years with once and twice a year
impulse actions and total number of new infected cattle is calculated as an output variable.
PRCC values between these input and output variables, and corresponding p-values are
calculated under a null hypothesis assuming PRCC value is zero. Table 2.7 shows statistical
results of parameter in the model with impulse actions twice a year.
If we assume that the significant level of α = 0.05, then there are significant evidence
to conclude that the highlighted parameters have some impact on the total number of new
infected cattle in the model with impulse actions once a year. We also perform LHS-PRCC
with the model with impulse actions twice a year, we observed same list of parameters that
are statistically significant. These results intuitively make sense for instance, we have more
adult cattle in the ranch than juvenile and transmission rates are the main factors that
impacts the number of new infected cattle, therefore we expect the transmission rate βAA to
be statistically significant.
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Table 2.7: The result of PRCC and p-values in sensitivity analysis for the model with
impulse actions once a year
PRM. PRCC p-value Baseline V. Lower B. Upper B.
b 0.36 1.9e-10 0.00078 0.00039 0.0012
µJ -0.01 0.86 6.4e-05 3.2e-05 9.6e-05
µA -0.54 1.7e-24 0.00078 0.00039 0.0012
θJ 0.033 0.57 0.007 0.0035 0.011
θA 0.4 8.6e-13 0.014 0.007 0.021
K -0.5 5.1e-20 34 17 51
k -0.44 1.2e-15 0.011 0.0056 0.017
σ -0.022 0.71 0.079 0.039 0.12
σv 0.023 0.69 0.039 0.02 0.059
q -0.13 0.022 0.27 0.14 0.41
qv -0.0012 0.98 0.14 0.068 0.2
γJ -0.18 0.0023 0.0055 0.0027 0.0082
γA -0.63 4e-34 0.0027 0.0014 0.0041
µIJ -0.16 0.0058 0.033 0.017 0.05
µIA -0.87 7.3e-94 0.0067 0.0033 0.01
βJJ 0.011 0.85 5e-05 2.5e-05 7.5e-05
βJA 0.39 1.5e-12 0.0001 5e-05 0.00015
βJ 0.1 0.085 0.0006 0.0003 0.0009
βAA 0.93 2.5e-129 0.0001 5e-05 0.00015
βAJ 0.2 0.00064 0.0001 5e-05 0.00015




We have studied two mathematical models of leptospirosis to analyze the behavior of
leptospirosis and the consequences of control programs in the cattle ranch. The preliminary
model 2.1 suggests the ranch managers need to apply some control programs to eradicate
leptospirosis or reduce the damage due to leptospirosis in the ranch. As shown in Figure
2.12, leptospirosis spreads out fast and causes significant number of deaths in the ranch in a
few months. The model with impulse actions (2.10) shows the application of impulse actions
reduce the number of deaths and the number of infected cattle in the ranch as shown in
Figure 2.12. However, the application of impulse actions once a year is not sufficient in
order for eradicate leptospirosis in the ranch. The number of new infected cattle increases
gradually with the application of impulse actions twice a year. Therefore, the application of
impulse actions need to be done more frequently. The application of impulse actions twice
a year eliminates leptospirosis in the ranch after their applications for sufficiently long time.
These results are coincide with the ideal treatment suggested in the literature, in which
vaccines are applied twice a year. This practice can eradicate the disease, and even more
through the target reproduction number analysis in section 2.2.3 it is possible to control the
disease only by applying vaccination to the adult cattle.
This chapter is collaboration with Prof. Suzanne Lenhart, University of Tennessee,
Knoxville, Prof. Jorge X. Velasco-Hernandez, Instituto de Matematicas UNAM and Prof.
David Baca Carrasco, Instituto Tecnológico de Sonora.
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Chapter 3
A mathematical model for
cost-effectiveness analysis and early
detection of leptospirosis in human
3.1 Introduction
Leptospirosis is a neglected zoonotic diseases caused by various types of pathogenic
Leptospira including more than 9 genospecies and over 200 serovars. While leptospirosis has
been an increasing health problem in urban regions in developing countries due to hygiene
and overcrowding issues, and it is also a life-threatening disease in developed countries due to
climate conditions [4, 51, 21]. This life-threatening disease is recognized as one of main causes
of pulmonary haemorrhage syndrome, however, there are not a lot of studies estimating
mortality and morbidity of leptospirosis for the global burden [16]. One study estimates
1.03 million cases with 58,900 deaths annually, resulting in a total of approximately 2.9
million Disability Adjusted Life Years (DALY) ( a health metric used by the World Health
Organization (WHO) ). This is more than 70% of the global DALY level of cholera estimated
in 2010, and the DALY levels are higher in tropical regions such as South East Asia, Central
and South America [62].
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Transmission of leptospirosis occurs in humans through contact with infected animals or
soil and water contaminated by infected animals’ urine. Therefore, the transmission rate of
leptospirosis varies depending on the climate, rainfall and occupations ( change contact rate
of susceptible humans to the bacteria). Since the transmission rate increases in flood seasons
outbreak happens during flood seasons. While rodents are the main reservoir hosts, humans
are accidental hosts that are less likely to cause infection [19, 4]. Clinical presentation of
leptospirosis varies from self-limited anicteric febrile illness with or without meningitis to
severe and potentially lethal multisystem illness with jaundice and renal failure, and even
death [61, 60, 21]. The average incubation period is 1 or 2 weeks, with a range of 2 days
to 30 days. The most common symptoms are chills, headache myalgia, and abdominal pain.
Due to common symptoms with other diseases such as dengue and malaria, misdiagnosis of
leptospirosis is very common in many endemic countries [44, 4].
In humans, antibiotic therapy is the most common and effective method as compared with
vaccination to provide immunity against leptospirosis. However, early and correct diagnosis
of leptospirosis is crucial for antibiotics to provide benefit. There are several laboratory tests
available for diagnosis of leptospirosis, but their sensitivity and specificity values are low and
their usefulness are still under discussion [20, 60]. Antibiotic treatment is suggested as soon
as leptospirosis is suspected, and physician should not wait for the test result [44]. While a
diverse range of antibiotics is available in some countries, doxycycline is potentially the best
option for initial antimicrobial treatment [47, 61]. Doxycycline is effective against most of
Leptospira, bacteria causing infection, so it is extensively recommended and used in many
countries. It has been shown that doxycycline decreased the duration of illness by 2 days
and also affected fever, malaise, headache, and myalgias without any side effects [14, 41].
There were several studies discussing the effectiveness of doxycycline and other antibiotics
in treatment of leptospirosis [20, 14, 47]. In addition, there has been some work about
accuracy and usefulness of the diagnostic tests for leptospirosis, and the comparison of their
performances [61, 48]. Several papers pointed out the global burden of leptospirosis in terms
of DALYs [21, 62, 16]. There is a study discussing the strategies for treatment of suspected
leptospirosis by a Thailand group [60]. This study compared treatment strategies with and
without tests confirmation by using a framework of cost-benefit analysis conducted at 5
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hospitals in Thailand between July 2003 and January 2005 and accounted for all direct
medical costs in diagnosing and treating patients. The outcomes are measured respect to
length of fever after treatment and then converted to productivity losses for the full economic
costs. They found that empirical doxycycline treatment to be the most effective way without
waiting for a test confirmation due to their low sensitivity and performance time. However,
they did not focus on early detection of leptospirosis while doxycycline provides greatest
benefit in early stage of disease.
In this study, our goal is to determine a treatment strategy for patients coming into
a hospital and being suspected of leptospirosis. We developed a computational algorithm
under stochasticity by using Markov-cycle tree and Monte Carlo simulations similar to the
study by Sonnenberg and Beck in [59]. Our mathematical model finds an optimal treatment
strategy for the patients depending on whether they have severe or mild symptoms and
whether they are late case patients who are coming to the hospital after seven days of onset
of their symptoms or early case patients who are coming to the hospital within seven days
of onset of their symptoms. The model is a useful tool to determine the treatment strategies
during flood session for a large group of patients. Due to the lack of data related to our
problem, some of the parameter values are chosen according to some expert opinions [43, 24].
Imagine that a group of patients shows up at a hospital, the physicians know whether their
symptoms are severe or mild and whether the patients are late or early case. The physicians
do not know whether those symptoms are caused by leptospirosis or some other disease and
whether the mild symptom patients will develop severe symptoms or stay with their mild
symptoms. Under these circumstances, the physicians have six different treatment strategies
as described in Figure 3.1 and they have to choose one of these six options to minimize






S2 Giving doxycycline treatment without any test
S3 Giving doxycycline treatment according to PCR+RAP tests result
S4 Giving doxycycline treatment according to RAP test result
S5 Giving doxycycline treatment according to MAT test result
S5 Giving doxycycline treatment according to PCR test result
Figure 3.1: The choice of physicians
3.2 Model formulation
A cost-effectiveness analysis model with various scenarios is proposed to compare six
treatment strategies regarding to the corresponding costs for leptospirosis and non-
leptospirosis patients and indirectly maximize the number of early detected leptospirosis
patients. Before introducing the model formulation we give some background about three
diagnostic tests and assumptions that are used in this study.
Polymerase Chain Reaction based assay (PCR): They are classified as Conven-
tional (including nested) and Real-time PCRs. As a molecular diagnosis test PCRs detect
genes, which is present in the bacteria, such as gyrB, rrs (16S rRNA gene), secY or genes
restricted to pathogenic Leptospira supplement such as lipL32, lfb1, ligA, ligB2. PCRs are
effective diagnosis tests within first 5 to 15 days after the disease onset. A positive PCR
result usually refers to presence of a pathogenic Leptospira species in the sample, however,
the serovar type is not specifed [44]. These tests commonly used because of their higher
sensitivity and early diagnosis in acute stages of diseases. However, performing PCR requires
highly skilled personel and a laboratory with special equipments. Specimen collection can
be from blood, urine, CSF or tissues. The processing time takes from couple hours to a day
56
depending on the type of PCR used and they are recommended to be used with one of rapid
tests such as IgM ELISA to increase sensitivity in the first phase of the disease[11, 48, 44].
Microscopic Agglutination Test (MAT): As a serological test, MAT detects both
immunoglobulin M (IgM) and immunoglobulin G (IgG) class agglutinating antibodies. MAT
starts to give positive results from 10 to 12 days after the disease onset, so a positive result
is considered a confirmed case. While the sensitivity is 41% during first week, it becomes
82% to 96% during second and third weeks. Performing MAT is very complicated and
requires reference laboratories, such as the maintenance of a large panel of live pathogenic
Leptospira standard cultures. Incomplete procedure while performing the test causes false
negative results. Specimen collection must be from the blood and the processing time takes
several weeks [44, 45].
Rapid screening tests: These tests just provide quick results which are not necessarily
accurate, so the diagnosis is not necessarily to be early. They are easy to use and do not
require an expert to perform. While their reading and interpretation are simple, they still
require some training to perform accurately. They are mostly IgM detection tests. Since
IgM cannot be detectable before second week of disease onset, these tests have very low
sensitivity in the early acute stage of the illness. There are several rapid tests available, and
lateral flow assays (LFA) is one of them, which is used in the decision process of this work.
LFA can be applied to the patient at the bedside, as whole blood can be used for testing.
While LFA results are available in 10 minutes, it does not confirm a case. In addition, it
cannot detect antibodies against serovars belonging to the serogroup Icterohaemorrhagiae,
so its result cannot be generalizable [48, 44].
Assumptions:
• The patients showing up at the hospital have similar symptoms to leptospirosis, such
as fever, headache, chills, muscle aches, vomiting, etc.
• The effect of doxycycline is known respect to DALYs for leptospirosis and non-
leptospirosis diseases such as influenza and dengue fevers.
• The tests diagnose only leptospirosis patients. The physicians believe that if the
test result of a patient is positive, then the patient has leptospirosis and they give
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doxycycline. If the test result of a patient is negative, then the patient does not have
leptospirosis and they do not give doxycycline.
3.2.1 Patients classification
Regarding the assumptions we developed a computational algorithm and we start with
classifying the patients according to their features. Recall that the physicians know the
severity of symptoms and the duration of symptoms, however, they do not know whether
these symptoms are caused by leptospirosis or some other diseases and whether the patients
with mild symptoms will develop severe symptoms or stay with their mild symptoms.
Therefore, each patient has four features: 1) Late or early case, 2) Severe or mild symptoms,
3) Severe or mild pathway, 4) leptospirosis or non-leptospirosis. Two of these four features
are known by the physicians. We classified the patients according to their known features.
Based on the known features, there are four different classes
• Late case, severe symptoms patients
• Late case, mild symptoms patients
• Early case, severe symptoms patients
• Early case, mild symptoms patients.
Each class has different transmission probabilities, so we should find a treatment strategy
for each class separately.
3.2.2 Patients identification
We assigned the patients’ unknown features by using the probability of having leptospirosis
and the conditional probability of leptospirosis or non-leptospirosis patients moving to a
severe pathway. To assign whether a patient has leptospirosis or not, a random number is
drawn for the patient from an uniform distribution defined on the interval [0, 1], if the random
number is less than the probability of having leptospirosis then the patient is assigned to
have leptospirosis, otherwise, non-leptospirosis.
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To assign whether the patient is on the mild or severe pathway, another random number
is drawn for the patient from an uniform distribution defined on the interval [0, 1], if the
random number is less than the conditional probability of leptospirosis or non-leptospirosis
patients moving to severe pathway then the patient is assigned to be on severe pathway,
otherwise, on mild pathway. Figure 3.2 shows the diagram of patient identification for late
case, severe symptoms patient, where p1 is the probability of having leptospirosis when a
patient is in late case, severe symptoms class. Since the patients in this class have already
had severe symptoms, they are severe pathway patients.
Late case mild symptoms class patients have a slightly different diagram since they
can stay in mild pathway or they can make a transition to severe pathway depending on
the conditional probability of leptospirosis or non-leptospirosis patients moving to severe
pathway. Figure 3.3 shows the diagram of patient identification for late case, mild symptoms
patients, where p2 is the probability of having leptospirosis for late case, mild symptoms class
patients, p3 is the conditional probability of leptospirosis patients in late case, mild symptoms
class moving to severe pathway, and p4 is the conditional probability of non-leptospirosis
patients in late case, severe symptoms class moving to severe pathway.
This process is same for early case, severe symptoms class and early case, mild symptoms
class. Hereby a table can be generated for large number of patients for each class such that
each row represents the patients’ identification as shown in Table 3.1, for instance the first

































Figure 3.3: The diagram for identifying late case, mild symptoms patients


















There are six choices for the physicians to make a decision. We have assigned each choice
with a probability di where i = 1, 2, ..., 6 and d1 + d2 + d3 + d4 + d5 + d6 = 1. Notice that
the distribution of d = (d1, d2, d3, d4, d5, d6) is the only choice of the physicians that affects
the overall cost in the model. Thus we will get a different set of d = (d1, d2, d3, d4, d5, d6) for
the optimal strategies depending on the classes and the goal is to find the best distribution
of d for each class by evaluating the costs associated with Table 3.1 at each distribution.
Therefore, the cost function depends on the distributions in the model. We are going to tell
more about this part in the cost calculation section.
Figure 3.4 shows the choices of physicians corresponding each distribution. There are
as many as distributions of d can be generated, however we are going to evaluate the cost
function with certain choices of these distributions only. There are six simple distributions,
as given below.
• (1, 0, 0, 0, 0, 0) Doing nothing
• (0, 1, 0, 0, 0, 0) Giving doxycycline treatment without any test
• (0, 0, 1, 0, 0, 0) Giving doxycycline treatment according to PCR+RAP tests result
• (0, 0, 0, 1, 0, 0) Giving doxycycline treatment according to RAP test result
• (0, 0, 0, 0, 1, 0) Giving doxycycline treatment according to MAT test result
• (0, 0, 0, 0, 0, 1) Giving doxycycline treatment according to PCR test result
These six distributions are obtained by using {0, 1}. If we want to use {0, 0.5, 1}, then we
come up with a table with 21 different distributions. Table 3.2 shows a list of twenty-one
different distributions by using 0, 1 and 0.5. Each distribution has different meaning, such
as (0.5, 0, 0, 0, 0.5, 0) means applying the first strategy with the probability 0.5 and applying
the fifth strategy with the probability 0.5.
To decide which strategy to choose for more general distributions, such as (d1, d2, d3, d4, d5, d6) =






















dk = 1, i = 1, 2, 3, 4, 5, 6
For a given random number r, if lj ≤ r < lj+1 then choose path lj+1, where l0 = 0 and
j = 0, 1, 2, 3, 4, 5
|l0 |l1 |l2 |l3 |l4 |l5 |l6
For instance, (d1, d2, d3, d4, d5, d6) = (0.1, 0, 0.2, 0.2, 0.4, 0.1), then ~l = (l0, l1, l2, l3, l4, l5, l6) =
(0, 0.1, 0.1, 0.3, 0.5, 0.9, 1). Assume the chosen random number r = 0.4, then the algorithm
choose path l4 which means choosing strategy 4 since the random number is in [l3, l4].
3.2.4 Evaluation of each strategy
After the algorithm decides the choice of the strategy, the model uses the sensitivity and
specificity of the tests to find out the tests’ result. The sensitivity of a test is the performance
of detecting the true positives, given as the following
P {+Test|Disease} = TP
TP + FN
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Table 3.2: Twenty-one distributions generated by 0, 0.5, 1
Index d1 d2 d3 d4 d5 d6
1 1 0 0 0 0 0
2 0.5 0.5 0 0 0 0
3 0 1 0 0 0 0
4 0.5 0 0.5 0 0 0
5 0 0.5 0.5 0 0 0
6 0 0 1 0 0 0
7 0.5 0 0 0.5 0 0
8 0 0.5 0 0.5 0 0
9 0 0 0.5 0.5 0 0
10 0 0 0 1 0 0
11 0.5 0 0 0 0.5 0
12 0 0.5 0 0 0.5 0
13 0 0 0.5 0 0.5 0
14 0 0 0 0.5 0.5 0
15 0 0 0 0 1 0
16 0.5 0 0 0 0 0.5
17 0 0.5 0 0 0 0.5
18 0 0 0.5 0 0 0.5
19 0 0 0 0.5 0 0.5
20 0 0 0 0 0.5 0.5
21 0 0 0 0 0 1
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where TP is the number of true positives and FN is the number of false negatives.
Similarly, the specificity of a test is the performance of detecting the true negatives, given
as the following
P {−Test|No Disease} = TN
TN + FP
where TN is the number of true negatives and FP is the number of false positives [34, 2].
One of the physicians choices is to use combination of two tests, PCR+Rapid, and we
assume either of these test positive, the physicians consider the tests’ results to be positive.
Therefore, the sensitivity of this choice is calculated as following
P {(+T1) or (+T2)|Disease} =P {+T1|Disease}+ P {+T2|Disease}
− P {+T1|Disease}P {+T2|Disease}
and the specificity by
P {(−T1) and (−T2)|No Disease} = P {−T1|No Disease}P {−T2|No Disease}
.
To decide whether the test result is positive or negative for a patient having leptospirosis
in Table 3.1, a random number is drawn for the patient from an uniform distribution defined
on the interval [0, 1]. If the random number is less than the sensitivity of the test, then we
decide the test result is positive, otherwise the test result is negative. To decide whether
the test result is positive or negative for a patient not having leptospirosis in Table 3.1, a
random number is drawn for the patient from an uniform distribution defined on the interval
[0, 1]. If the random number is less than the specificity of the test, then we decide the test
result is negative, otherwise the test result is positive.
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3.2.5 Accurate and inaccurate actions with and without the tests
Notice that the patients are going to be given doxycycline or not after the decision of the test
result. Therefore, doxycycline might be given to the patients who do not have leptospirosis
if their test result is positive. Similarly, doxycycline might not be given to the patients who
have leptospirosis if their test result is negative.
Figure 3.5 shows the diagram of evaluation of each strategy for late case, severe symptoms
class. We are illustrating all possible consequences that might happen after a test result in
the last green column of Figure 3.5. For instance, the first row of the last column indicates
leptospirosis patient getting doxycycline, and the second row of the last column indicates
non-leptospirosis patient getting doxycycline.
Late case, mild symptoms class has a slightly different diagram since they have mild
symptoms and they may develop severe symptoms as shown in Figure 3.6
The rest of the diagrams follow the same for patients who are not getting doxycycline.
Figures 3.5 and 3.6 are same for early case, severe and mild symptoms class.





























Doxycycline not is given
Non leptospirosis
Severe Pathway
Doxycycline not is given
Figure 3.5: After test results, the diagram of each strategy for late case, severe symptoms
class
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Doxycycline not is given
Figure 3.6: After test results, the diagram of each strategy for late case, mild symptoms
class
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Since the tests are given not only to detect leptospirosis patients but also to prevent
inaccurate treatment of non-leptospirosis patients, the accuracy of treatment with test
confirmation must be counted. Therefore the accurate test confirmation must reduce overall
cost for leptospirosis and non-leptospirosis patients. A leptospirosis patient given doxycycline
with a positive test result must have lower cost values with respect to death and DALY
than a leptospirosis patient given doxycycline without a test confirmation. Similarly a non-
leptospirosis patient not given doxycycline with a negative test result must have lower cost
values than a non-leptospirosis patient not given doxycycline without a test confirmation.
Figure 3.7 depicts the all possible cases of test outcomes for a patient. The last
column points out accurate and inaccurate actions with and without test confirmation. For
instance, the first row of the last column in Figure 3.7 indicates an accurate action with
a test confirmation, however the second row indicates an accurate action without a test
confirmation.
3.2.6 Cost calculation
Three types of values are counted in the model: i) DALYs which is the years that the patients
lose due to disability and death, ii) the number of deaths due to the diseases and iii) the
monetary cost during hospital process. These values are going to be calculated separately
for each of four classes. The goal is to find the best choice for the physicians in Figure 3.4
that minimizes each of these cost values.
Note that no matter which strategy that the physician uses, the patients in Table 3.1 are
going to be in one of four categories: leptospirosis patients receiving doxycycline, leptospirosis
patients not receiving doxycycline, non-leptospirosis patients receiving doxycycline, and non-
leptospirosis patients not receiving doxycycline. Therefore, the cost values are calculated
based on the patients’ pathways, whether the patients are receiving doxycycline, and whether
the patients have leptospirosis, and the patients can be given any of the tests as shown in
Figures 3.5-3.7 and as discussed in subsection 3.2.5. The costs depend also on the known
two features of the patients. Hence, if we minimize the following objective function of the

































{c1(d) + c2(d) + c3(d) + c4(d)}
where
• d = (d1, d2, d3, d4, d5, d6) is the distribution for the choice of the physicians
• c1(d) is the cost for leptospirosis patients receiving doxycycline
• c2(d) is the cost for leptospirosis patients not receiving doxycycline
• c3(d) is the cost for non-leptospirosis patients receiving doxycycline
• c4(d) is the cost for non-leptospirosis patients not receiving doxycycline.
DALYs: This cost value is calculated by using:
DALYs=YLLs+YLDs,
where YLLs represents the years lost due to death and YLDs represents the years lost due to
disability. Both are measured in years. One can convert this unit to dollar unit by converting
one year DALYs loss to monetary cost. We can assume that YLLs is 20 years for death of any
patient according to the expert opinions [43, 24]. However YLDs depend on the situations
that whether the patient is on severe or mild pathways, the patient receiving doxycycline,
the patient has leptospirosis, and the patient takes any of the tests. The values in Tables
3.3 and 3.4 are found based on these situations. The values in these tables are adjusted
according to the expert opinions [43, 24]. Table 3.3 represents calculated YLDs costs of
patients depending on whether they receive doxycycline, they have leptospirosis, they are on
severe or mild pathway.




{x1(d) + x2(d) + x3(d) + x4(d)}
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Table 3.3: YLDs values
Parameter Description Value
YLDs YLDs value for leptospirosis patients on severe
pathway receiving doxycycline
0.0302
YLDs YLDs value for non-leptospirosis patients on
severe pathway receiving doxycycline
0.05
YLDs YLDs value for leptospirosis patients on mild
pathway receiving doxycycline
0.0102
YLDs YLDs value for non-leptospirosis patients on
mild pathway receiving doxycycline
0.015
YLDs YLDs value for leptospirosis patients on severe
pathway not receiving doxycycline
0.0604
YLDs YLDs value for non-leptospirosis patients on
severe pathway not receiving doxycycline
0.0604
YLDs YLDs value for leptospirosis patients on mild
pathway not receiving doxycycline
0.0205
YLDs YLDs value for non-leptospirosis patients on




• x1(d) is the total DALYs cost for leptospirosis patients receiving doxycycline
• x2(d) is the total DALYs cost for leptospirosis patients not receiving doxycycline
• x3(d) is the total DALYs cost for non-leptospirosis patients receiving doxycycline
• x4(d) is the total DALYs cost for non-leptospirosis patients not receiving doxycycline
Recall that an accurate test confirmation reduces the overall cost, as discussed earlier in
subsection 3.2.5. Therefore, we need to use the weight factor in Table 3.4 for the values in
Table 3.3 to reduce the DALYs values for the patients with accurate test results. The values
in Table 3.4 are adjusted according to the expert opinions [43, 24] and the studies in [60, 62].
Table 3.4 represents the weight factors on YLDs costs for the patients accurately detected.
For instance, if a leptospirosis patient takes a test and the result of the test is positive, then
we multiple YLDs value by half which means we reduce YLDs value by half. However, if
a leptospirosis patient takes a test and the result of the test is negative, then we multiple
YLDs value by one which means we do not change YLDs value.
Since doxycycline is most effective in the early stage of leptospirosis, a lower YLDs
are counted for early case leptospirosis patients. Thus, the model is indirectly forced
to maximize the number of early detected leptospirosis cases while finding the treatment
strategy minimizing the costs.
DEATHS: The number of deaths are counted only for the patients on the severe pathway.
This number of deaths can be converted dollars by converting one death of a patient to
monetary cost.
The number of deaths is calculated by using the probability of deaths and the probability
of death depends on whether the patients receive doxycycline, the patients have leptospirosis,
and the patients take any of the tests. To decide whether a patient dies, we draw a random
number from an uniform distribution defined on the interval [0, 1] for patients on severe
pathway in Table 3.1, if the random number is less than the probability of deaths for their
feature then we assume the patient dies. Table 3.5 represents the probability of deaths for
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Table 3.4: Weight factors on YLDs due to accurate test confirmation
Parameter Description Value
m1 Weight factor on YLDs for leptospirosis
patient with a positive test result compared to
no test options
0.5
m2 Weight factor on YLDs for leptospirosis
patient with a negative test result compared to
no test options
1
m3 Weight factor on YLDs for non-leptospirosis
patient with a positive test result compared to
no test options
1
m4 Weight factor on YLDs for non-leptospirosis
patient with a negative test result compared to
no test options
0.3
Table 3.5: Probability of deaths
Parameter Description Value
q1 Probability of leptospirosis patients receiving
doxycycline to die
0.1
q2 Probability of leptospirosis patients not
receiving doxycycline to die
0.5
q3 Probability of non-leptospirosis patients
receiving doxycycline to die
0.05
q4 Probability of non-leptospirosis patients not
receiving doxycycline to die
0.05
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patients depending on whether they receive doxycycline or they have leptospirosis and
these probabilities are chosen according to the expert opinions [43, 24] and the studies in
[60, 62].




{y1(d) + y2(d) + y3(d) + y4(d)}
where
• y1(d) is total number of deaths for leptospirosis patients receiving doxycycline
• y2(d) is total number of deaths for leptospirosis patients not receiving doxycycline
• y3(d) is total number of deaths for non-leptospirosis patients receiving doxycycline
• y4(d) is total number of deaths for non-leptospirosis patients not receiving doxycycline.
Recall that an accurate test confirmation reduces the overall cost, as discussed earlier in
subsection 3.2.5. Therefore, we need to use the weight factors in Table 3.6 for the values in
Table 3.5 to reduce the number of deaths for the patients with accurate test results. For
instance, if a leptospirosis patient takes a test and the result of the test is positive, then
we multiply the death probability by half, which means we reduce the death probability by
half. However, if a leptospirosis patient is given a test and the result of the test is negative,
then we multiply the death probability by one, which means we do not change the death
probability. These weight factors are adjusted according to the expert opinions [43, 24] and
the studies in [62]. Since doxycycline is most effective in the early stage of leptospirosis, a
lower probability of death is counted for early case leptospirosis patients in the algorithm.
We consider the probability of deaths for the early stage of leptospirosis patients to be half
of the late stage of leptospirosis patients. Thus, the model is indirectly forced to maximize
the number of early detected leptospirosis cases.
HOSPITAL: The costs in the hospital for a patient depend on four different values:
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Table 3.6: Weight factors on the death probabilities due to accurate test confirmation
Parameter Description Value
n1 Weight factor on the death probability for
leptospirosis patient with a positive test result
compared to no test option
0.5
n2 Weight factor on the death probability for
non-leptospirosis patient with a positive test
result compared to no test option
1
n3 Weight factor on the death probability for
leptospirosis patient with a negative test result
compared to no test option
1
n4 Weight factor on the death probability for
non-leptospirosis patient with a negative test




• Days staying in the hospital
• Supportive treatments for test confirmed patients.
Medicine, tests and supportive treatment costs depend on the physician’s choice, however, the
number of days staying in the hospital depends on whether the patients receive doxycycline,
the patients have leptospirosis.
We assume only patients on severe pathways stay in the hospital. In order to calculate
the hospital costs we use the values in Tables 3.7 and 3.8. Table 3.7 represents the dollar cost
of doxycycline and the tests, and Table 3.8 represents the dollar cost of patients daily staying
in the hospital depending on whether they receive doxycycline or they have leptospirosis.
These values are adjusted according to the expert opinions [43, 24] and the studies in [48, 60].
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{z1(d) + z2(d) + z3(d) + z4(d)}
where
• z1(d) is the total hospital cost for leptospirosis patients receiving doxycycline
• z2(d) is the total hospital cost for leptospirosis patients not receiving doxycycline
• z3(d) is the total hospital cost for non-leptospirosis patients receiving doxycycline
• z4(d) is the total hospital cost for non-leptospirosis patients not receiving doxycycline.
In addition, an accurate test confirmation reduces the overall cost, as discussed earlier in
subsection 3.2.5. Thus we use the weight factors in Table 3.9 for the values in Table 3.8 to
reduce costs of hospital stays for the patients with accurate test results. The values in Table
3.9 are adjusted according to the expert opinions [43, 24]. Table 3.9 represents the weight
factors on hospital costs for the patients accurately detected. For instance, if a leptospirosis
patient takes a test and the result of the test is positive, then we multiply the hospital cost
by half which means we reduce the hospital cost by half. However, if a leptospirosis patient
takes a test and the result of the test is negative, then we multiply the hospital cost by one
which means we do not change the hospital cost.
Since doxycycline is most effective in the early stage of leptospirosis, lower costs of hospital
stays is counted for early case leptospirosis patients.
Table 3.7: The treatment costs
Parameter Description Value
Doxycycline Medicine $10
Rapid test Diagnostic test $10
PCR test Diagnostic test $60
MAT test Diagnostic test $100
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Table 3.8: Costs of hospital stays
Description Daily cost
Leptospirosis patients receiving doxycycline $6000
Non-leptospirosis patients receiving doxycycline $10000
Leptospirosis patients not receiving doxycycline $12000
Non-leptospirosis patients not receiving doxycycline $12000
Table 3.9: Weight factors on hospital cost due to accurate test confirmation
Parameter Description Value
r1 Weight factor on hospital cost for leptospirosis
patient with a positive test confirmation
compared to no test option
0.5
r2 Weight factor on hospital cost for leptospirosis
patient with a negative test result compared to
no test option
1
r3 Weight factor on hospital cost for
non-leptospirosis patient with a negative test
confirmation compared to no test option
0.3
r4 Weight factor on hospital cost for
non-leptospirosis patient with a positive test
result compared to no test option
1
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Thus, the model is indirectly forced to maximize the number of early detected
leptospirosis cases. In addition, since supportive treatments, for instance special health
care like dialysis, are given to the test confirmed patients, the monetary cost of supportive
treatments are counted for patients with confirmed tests. We chose reasonable values in
Table 3.10.
3.2.7 Combined cost function
Before we move to the simulations, one can combine the functions of distributions
x(d), y(d), z(d) to form the following total cost function of DALYs, deaths, hospital costs
in order to make final decisions
T (d) = ax(d) + by(d) + z(d)
Table 3.10: Monetary costs for supportive treatment
Parameter Description Value
s1 Supportive treatment cost for leptospirosis
patient with a positive test confirmation
compared to no test option
$1000
s2 Supportive treatment cost for leptospirosis
patient with a negative test result compared to
no test option
$500
s3 Supportive treatment cost for non-leptospirosis
patient with a negative test confirmation
compared to no test option
$500
s4 Supportive treatment cost for non-leptospirosis




where a, b are corresponding conversion constants for DALYs and deaths, and d is the
distribution of strategy. The unit of the total cost function T (d) is dollars, the unit of a is
dollars per DALY and the unit of b is dollars per death.
Recall that we assume the death of a patient costs 20 YLLs, thus we can draw a
relationship b = 20a. Therefore, we only need to determine the value of a. It is hard
to decide the value of a, but we may evaluate the total cost function for some different
values of a to see how these different values change the final decision.
3.3 Simulations and results
In this section, we show some of the simulation results with available parameters for six
simple distributions and the distribution in Table 3.2. The model is run with 1000 patients
for each class. The parameters used in these simulations are given in Table 3.11 and 3.12
and the values in Table 3.12 are adjusted according to the expert opinions [43, 24] and a
hospital results in Thailand [60].
3.3.1 Simulations with respect to the number of patients
The following tables 3.13- 3.16 show the results of 1000 patients with corresponding strategy
and one single run for each class. We want to see the outcomes of each strategy with
respect to the number of positive outcomes, leptospirosis detected cases, and accurate action
results. Positive outcome means the number of patients with positive test results out of
1000 patients no matter whether the patients truly have leptospirosis or not. Leptospirosis
detected cases means the number of positive tests for the patients truly having leptospirosis
out of 1000 patients. Accurate action means the patient has leptospirosis and their test
result is positive, or the patient does not have leptospirosis and their test result is negative.
For example in Table 3.13 there are 88 leptospirosis cases, 88 leptospirosis on severe pathway,
and 912 non-leptospirosis on severe pathways out of 1000 patients in simulation of late case,
severe symptoms class. The strategies giving doxycycline according to PCR+Rapid gives
72 positive results, 75 accurately detected leptospirosis cases and 936 accurate actions. One
can read the other Tables 3.14 -3.16 for the other classes in a similar way.
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PCR 34% 86% 99% 100% [48, 51, 4]
MAT 82% 41% 100% 95.7% [44, 45, 61]
LFA 81% 34% 96% 88 % [48, 60]
Table 3.12: Transmission probabilities. L S: Late case, severe symptoms class, L M: Late
case, mild symptoms class, E S: Early case, severe symptoms class, E M: Early case, mild
symptoms class.
Parameter Description Class Value
p1 Prevalence leptospirosis L S 0.1
p2 Prevalence leptospirosis L M 0.1
p3 Transmission probability from mild pathway to
severe pathway in leptospirosis patients
L M 0.2
p4 Transmission probability from mild pathway to
severe pathway in Non leptospirosis patients
L M 0.2
p5 Prevalence leptospirosis E S 0.1
p6 Prevalence leptospirosis E M 0.1
p7 Transmission probability from mild pathway to
severe pathway in leptospirosis patients
E M 0.2
p8 Transmission probability from mild pathway to
severe pathway in Non leptospirosis patients
E M 0.2
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Table 3.13: Evaluating each strategy with respect to number of patients for late case,
severe symptoms class
Strategy Positive outcome Lepto. detected Accurate action
Doing Nothing - - 912
Doxycycline without test - - 88
PCR+Rapid 126 75 936
Rapid 113 71 941
MAT 72 72 984
PCR 44 33 934
Table 3.14: Evaluating each strategy with respect to number of patients for late case, mild
symptoms class
Strategy Positive outcome Lepto. detected Accurate action
Doing Nothing - - 889
Doxycycline without test - - 111
PCR+Rapid 135 96 946
Rapid 118 88 947
MAT 90 90 979
PCR 43 35 916
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Table 3.15: Evaluating each strategy with respect to number of patients for early case,
severe symptoms class
Strategy Positive outcome Lepto. detected Accurate action
Doing Nothing - - 891
Doxycycline without test - - 109
PCR+Rapid 196 96 887
Rapid 131 31 822
MAT 44 44 935
PCR 92 92 983
Table 3.16: Evaluating each strategy with respect to number of patients for early case,
mild symptoms class
Strategy Positive outcome Lepto. detected Accurate action
Doing Nothing - - 914
Doxycycline without test - - 86
PCR+Rapid 170 78 900
Rapid 120 28 850
MAT 32 32 946
PCR 76 76 990
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We observe from Tables 3.13 - 3.16 that choosing the strategy giving doxycycline
treatment according to PCR+Rapid tests result gives the maximum number of positive
outcomes and also the maximum number of early detected leptospirosis cases. On the other
hand, the strategy giving doxycycline treatment according to MAT test gives the maximum
number of accurate actions for late case patients and the strategy giving doxycycline
treatment according to PCR test gives the maximum number of accurate actions for early
case patients. Note that if we use the strategy giving doxycycline treatment without any
test, the maximum number of leptospirosis case will receive doxycycline.
3.3.2 Simulations with respect to DALYs, Death and Monetary
cost
The model has been run with 1000 patients and six simple distributions. Tables 3.17-3.20
list the results from the four classes. The results show the number of leptospirosis cases,
leptospirosis cases on severe pathways and the cost values with respect to each strategy for
each class. The first column refers to the strategy, the second column refers to the number
of deaths for the strategy, the third column refers the DALYs values for the strategy and the
fourth column refers to the dollars hospital cost for the strategy. The values of parameters
are used in the simulation are in Tables 3.3 - 3.12
The number of leptospirosis cases is 98, the number of leptospirosis on severe pathway
cases is 98 in the simulation of late case, severe symptoms class. For instance,consequence of
choosing the strategy giving doxycycline according to PCR+Rapid tests results is 45 deaths
out of 1000 patients, 940 DALYs years and $11, 030, 916 dollars of hospital cost. Similarly,
the conclusions from the other tables can be found. From tables 3.17-3.20, we observe
that choosing the strategy giving doxycycline treatment according to PCR+Rapid tests
result gives the minimum number of deaths and DALYs and the strategy giving doxycycline
treatment without any test gives the minimum hospital cost for the all four classes.
Since our model is stochastic we want to find the best strategies on average and to see the
uncertainty of the system. Therefore, the model has been run 100 times with 1000 patients
and six simple distributions.
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Table 3.17: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs for late case, severe symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 83 1704 $12,000,000
Doxycycline without test 57 1187 $6,344,204
PCR+Rapid 45 940 $11,030,916
Rapid 52 1081 $11,123,160
MAT 50 1041 $11,394,490
PCR 69 1422 $11,708,545
Table 3.18: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs for late case, mild symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 16 341 $2,364,000
Doxycycline without test 7 160 $1,029,714
PCR+Rapid 6 139 $2,200,334
Rapid 9 199 $2,177,864
MAT 10 219 $2,316,760
PCR 13 280 $2,345,996
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Table 3.19: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs for early case, severe symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 92 1884 $12,000,000
Doxycycline without test 46 966 $6,165,992
PCR+Rapid 46 960 $10,553,702
Rapid 73 1503 $11,096,828
MAT 69 1422 $11,646,565
PCR 48 1000 $11,144,325
Table 3.20: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs for early case, mild symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 14 301 $2,544,000
Doxycycline without test 5 120 $1,077,800
PCR+Rapid 5 119 $2,212,382
Rapid 10 221 $2,304,368
MAT 11 240 $2,526,745
PCR 6 139 $2,370,825
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The results in tables 3.21-3.24 show the average of 100 runs of number for leptospirosis
cases, severe pathway and cost values with respect to each distribution for each class. The
value of parameters used in the simulation are in Tables 3.3 - 3.12. From Tables 3.21-3.24,
we observe that the results of 100 runs are very similar to the results of one run. This shows
there is not significant uncertainty in the system.
3.3.3 Simulations with more distributions
We want to see whether the results vary when we run our model with more sets of
distributions. Therefore, the model has been run with same number of patients and the
parameters values in Tables 3.3-3.12. In addition the number of distributions increases to
21 and the distributions used in these simulations are given in Table 3.2.
In Tables 3.25-3.28, we list the results for the four classes. The tables show the number
of deaths, DALYs and the hospital cost for each index of strategies. Note that the index
of strategies refer to Table 3.2, for instance the strategy 13 is (d1, d2, d3, d4, d5, d6) =
(0, 0, 0.5, 0, 0.5, 0) which means choosing the strategy giving doxycycline treatment according
to PCR+Rapid tests result with probability of 0.5 and choosing the strategy giving
doxycycline treatment according to MAT test result with probability of 0.5. The results
with 21 distributions is same as the results with six-simple distributions, however, some
mix-strategies which means applying one strategy with a probability 0.5 and another one
with probability 0.5, might change the results. We observe that choosing the strategy giving
doxycycline treatment according to PCR+Rapid tests result gives the minimum number of
deaths and DALYs, and the strategy giving doxycycline treatment without any test gives the
minimum hospital costs for all of the classes. These results are true if we exclude the mixed-
strategies such as applying the strategies choosing the strategy giving doxycycline treatment
according to PCR+Rapid tests with probability 0.5 and the strategy giving doxycycline
treatment without any test with 0.5 probability.
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Table 3.21: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs in average of 100 runs for late case, severe symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 82 1681 $12,000,000
Doxycycline without test 50 1045 $6,330,470
PCR+Rapid 43 893 $11,026,717
Rapid 45 948 $11,077,002
MAT 45 933 $11,345,647
PCR 67 1380 $11,697,764
Table 3.22: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs in average of 100 runs for late case, mild symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 17 359 $2,412,720
Doxycycline without test 10 220 $1,061,786
PCR+Rapid 9 195 $2,258,662
Rapid 9 206 $2,225,596
MAT 9 202 $2,356,267
PCR 14 295 $2,398,347
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Table 3.23: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs in average of 100 runs for early case, severe symptoms class
Strategy Deaths DALYs Hospital cost
Doxycycline without test 81 1668 $12,000,000
Treatment 47 994 $6,186,124
PCR+Rapid 39 828 $10,534,490
Rapid 66 1367 $11,077,886
MAT 62 1278 $11,669,869
PCR 41 851 $11,154,008
Table 3.24: Evaluating each strategy with respect to the number of deaths, DALYs and
hospital costs in average of 100 runs for early case, mild symptoms class
Strategy Deaths DALYs Hospital cost
Doing Nothing 17 351 $2,377,560
Doxycycline without test 9 205 $1,015,295
PCR+Rapid 8 183 $2,117,789
Rapid 14 292 $2,178,337
MAT 13 272 $2,392,194
PCR 8 185 $2,258,733
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Table 3.25: The number of deaths, DALYs and hospital costs results from an average of
100 runs for late case, severe symptoms class with respect to each distributions
Distribution Deaths DALYs Hospital cost
1 83 1696 $12,000,000
2 66 1373 $9,165,376
3 50 1045 $6,339,539
4 63 1307 $11,519,943
5 47 981 $8,694,488
6 44 911 $11,045,011
7 65 1343 $11,555,707
8 47 983 $8,725,963
9 45 938 $11,069,599
10 46 961 $11,092,345
11 64 1328 $11,687,955
12 47 988 $8,857,481
13 44 927 $11,200,985
14 46 952 $11,226,681
15 45 939 $11,358,581
16 75 1543 $11,859,370
17 58 1209 $9,028,780
18 55 1142 $11,368,549
19 56 1171 $11,394,998
20 56 1167 $11,532,941
21 67 1385 $11,710,060
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Table 3.26: The number of deaths, DALYs and hospital costs results from an average of
100 runs for late case, mild symptoms class with respect to each distributions
Distribution Deaths DALYs Hospital cost
1 16 348 $2,407,320
2 14 293 $1,734,414
3 10 222 $1,060,733
4 13 272 $2,331,568
5 9 208 $1,657,969
6 9 192 $2,259,596
7 13 278 $2,315,821
8 10 210 $1,635,066
9 9 198 $2,242,134
10 9 204 $2,226,056
11 13 272 $2,379,555
12 10 213 $1,710,933
13 9 196 $2,309,306
14 9 203 $2,290,536
15 9 201 $2,356,484
16 15 318 $2,399,400
17 12 257 $1,725,987
18 11 242 $2,326,502
19 11 242 $2,307,808
20 11 248 $2,374,977
21 13 285 $2,392,039
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Table 3.27: The number of deaths, DALYs and hospital costs results from an average of
100 runs for early case, severe symptoms class with respect to each distributions
Distribution Deaths DALYs Hospital cost
1 83 1707 $12,000,000
2 66 1358 $9,082,943
3 48 1010 $6,178,789
4 62 1283 $11,268,048
5 45 937 $8,360,356
6 40 848 $10,522,540
7 75 1550 $11,528,385
8 58 1201 $8,627,555
9 54 1122 $10,793,127
10 67 1391 $11,060,510
11 73 1494 $11,821,991
12 56 1166 $8,912,578
13 51 1069 $11,083,174
14 65 1340 $11,355,726
15 62 1285 $11,649,412
16 62 1280 $11,567,241
17 44 928 $8,657,731
18 41 855 $10,832,447
19 54 1122 $11,102,453
20 52 1075 $11,397,321
21 41 860 $11,142,325
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Table 3.28: The number of deaths, DALYs and hospital costs results from an average of
100 runs for early case, mild symptoms class with respect to each distributions
Distribution Deaths DALYs Hospital cost
1 16 343 $2,382,240
2 12 268 $1,698,841
3 9 209 $1,017,930
4 12 262 $2,250,224
5 9 197 $1,575,007
6 8 180 $2,121,139
7 15 315 $2,284,441
8 11 248 $1,596,552
9 11 233 $2,153,397
10 13 280 $2,181,301
11 14 306 $2,391,607
12 10 227 $1,707,746
13 10 218 $2,257,765
14 13 270 $2,288,239
15 12 260 $2,394,730
16 12 261 $2,323,538
17 9 199 $1,646,112
18 8 184 $2,194,030
19 11 231 $2,221,111
20 10 228 $2,331,371
21 8 186 $2,264,019
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3.3.4 Simulations with different prevalences
The parameters given in Tables 3.3-3.12 are mostly country dependent. The prevalence of
leptospirosis is between 0.4 and 0.5 in some tropical regions, however, it varies from 0.1 to
0.2 in the most countries [60]. In this subsection we want to see how the results vary based
on the prevalence of leptospirosis. Therefore, we vary the prevalence of leptospirosis from
0.1 to 0.5 by keeping all other parameter values the same and find the best strategies giving
the minimum values based on the number of deaths, DALYs and hospital costs with respect
to each prevalence.
In Tables 3.29-3.32, the first column refers to the prevalence of leptospirosis, the second
column refers to the strategy giving the minimum number of deaths with respect to the
prevalence, the third column refers to the strategy giving the minimum DALYs with respect
to the prevalence and fourth columns refers to the strategy giving the minimum hospital
cost with respect to the prevalence.
The results suggests the strategy giving doxycycline treatment according to PCR+Rapid
tests result gives the minimum number of deaths and DALYs up to 0.2 prevalence, then
the best strategy with respect to three cost values when the prevalence is higher than 0.2 is
giving doxycycline treatment without any test.
3.3.5 Simulations with combined costs
Finally, we want to see the results of total cost functions, T (d) that was discussed in the
subsection 3.2.7. Since it is hard to determine the monetary cost per DALYs a, we have
varied it from $10,000 to $20,000 and find the best strategies giving the minimum costs for
each of this value. We run the model 100 times with 1000 patients and the parameters in
Tables 3.3-3.12 and then find the best strategy that gives minimum total cost value of the
average cost of 100 runs.
The tables 3.33-3.36 show the results. The first column refers to monetary costs per
DALYs, a, one can thinks as the monetary loss for one year if a patient is not economically
productive. The second column refers to the strategy giving the minimum total cost with
respect to monetary costs per DALYs, a. The third column refers total monetary cost, T (d).
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Table 3.29: The strategy giving the minimum the number of deaths, DALYs and hospital
costs with respect to each prevalence for late case, severe symptoms
Prevalence Deaths DALYs Hospital cost
0.1 PCR+Rapid PCR+Rapid Doxycycline without test
0.2 PCR+Rapid PCR+Rapid Doxycycline without test
0.3 Doxycycline without test Doxycycline without test Doxycycline without test
0.4 Doxycycline without test Doxycycline without test Doxycycline without test
0.5 Doxycycline without test Doxycycline without test Doxycycline without test
Table 3.30: The strategy giving the minimum the number of deaths, DALYs and hospital
costs with respect to each prevalence for late case, mild symptoms
Prevalence Deaths DALYs Hospital cost
0.1 PCR+Rapid PCR+Rapid Doxycycline without test
0.2 Doxycycline without test Doxycycline without test Doxycycline without test
0.3 Doxycycline without test Doxycycline without test Doxycycline without test
0.4 Doxycycline without test Doxycycline without test Doxycycline without test
0.5 Doxycycline without test Doxycycline without test Doxycycline without test
Table 3.31: The strategy giving the minimum the number of deaths, DALYs and hospital
costs with respect to each prevalence for early case, severe symptoms
Prevalence Deaths DALYs Hospital cost
0.1 PCR+Rapid PCR+Rapid Doxycycline without test
0.2 PCR+Rapid PCR+Rapid Doxycycline without test
0.3 Doxycycline without test Doxycycline without test Doxycycline without test
0.4 Doxycycline without test Doxycycline without test Doxycycline without test
0.5 Doxycycline without test Doxycycline without test Doxycycline without test
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Table 3.32: The strategy giving the minimum the number of deaths, DALYs and hospital
costs with respect to each prevalence for early case, mild symptoms
Prevalence Deaths DALYs Hospital cost
0.1 PCR+Rapid PCR+Rapid Doxycycline without test
0.2 PCR+Rapid PCR+Rapid Doxycycline without test
0.3 Doxycycline without test Doxycycline without test Doxycycline without test
0.4 Doxycycline without test Doxycycline without test Doxycycline without test
0.5 Doxycycline without test Doxycycline without test Doxycycline without test
Table 3.33: The strategy giving the minimum cost with respect to each monetary cost per
DALYs and total cost with this strategy for late case, severe symptoms
Cost per DALYs, a Strategy Total cost
$10,000 Doxycycline without test $26,840,847
$12,000 Doxycycline without test $30,372,956
$14,000 Doxycycline without test $35,087,189




Table 3.34: The strategy giving the minimum cost with respect to each monetary cost per
DALYs and total cost with this strategy for late case, mild symptoms







Table 3.35: The strategy giving the minimum cost with respect to each monetary cost per
DALYs and total cost with this strategy for early case, severe symptoms
Cost per DALYs, a Strategy Total cost
$10,000 Doxycycline without test $25,690,212






Table 3.36: The strategy giving the minimum cost with respect to each monetary cost per
DALYs and total cost with this strategy for early case, mild symptoms
Cost per DALYs, a Strategy Total cost
$10,000 Doxycycline without test $5,111,084.6
$12,000 Doxycycline without test $5,924,353.6
$14,000 Doxycycline without test $6,764,999
$16,000 PCR+Rapid $7,362,403.9
$18,000 Doxycycline without test $7,920,482.4
$20,000 PCR+Rapid $8,853,438.6
The results show the strategy giving doxycycline treatment without any test gives the
minimum total cost value for the monetary cost per DALYs from $10,000 to $16,000, then
the strategy giving doxycycline treatment according to PCR+Rapid tests result gives the
minimum total cost for the monetary cost per year higher than $16,000 for late case, severe
symptoms class.
The results show more precise strategy giving doxycycline treatment according to
PCR+Rapid tests result gives the minimum total cost for late case, mild symptoms class.
The results show the strategy giving doxycycline treatment without any test gives the
minimum total cost value for the monetary cost per DALYs from $10,000 to $12,000, then
the strategy giving doxycycline treatment according to PCR+Rapid tests result gives the
minimum total cost for the monetary cost per year higher than $12,000 for early case, severe
symptoms class.
The results show the strategy giving doxycycline treatment without any test gives the
minimum total cost value for the monetary cost per DALYs from $10,000 to $14,000, then
the best strategy switches between giving doxycycline treatment according to PCR+Rapid
tests result and giving doxycycline treatment without any test for the monetary cost per
year higher than $14,000 for early case, mild symptoms class.
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3.4 Conclusion
We have developed a stochastic computational model of cost-effectiveness and early detection
of leptospirosis for the patients suspected of leptospirosis. Most of parameters used in the
simulations of the model are adjusted according to the expert opinions [43, 24] and the studies
in [48, 60]. Note that our results and conclusions completely depend on these parameter
values. However, our model is applicable with different set of parameters and will determine
a different best strategy with different set of parameters.
Four strategies were discussed in this study: PCR+Rapid, Rapid, MAT and PCR. The
performance of each test depends on whether the patient is late or early case. The ranking of
the strategies in order of the number of true positives is PCR+Rapid, MAT, Rapid and PCR
from highest to lowest for late case patients, but for early case patients, the corresponding
order is PCR+Rapid, PCR, MAT and Rapid. The ranking of the strategies in order of the
number of accurate actions is MAT, Rapid, PCR+Rapid and PCR from highest to lowest,
for late case patients, however, for early case patients the corresponding order is PCR, MAT,
PCR+Rapid and Rapid. We may conclude that PCR itself does not perform well for late
case patients, but does perform well for early case patients this coincides with the results
in [48]. In addition, MAT does not give many false positive results particularly in late case
patients.
Three cost values were discussed in this study: deaths, DALYs and hospital cost. Each
strategy gives different result, depending on the corresponding costs. We observe that
choosing the strategy giving doxycycline treatment according to PCR+Rapid tests result
is the best strategy respect to deaths and DALYs, and the strategy giving doxycycline
treatment without any test is the best strategy respect to hospital costs for all four classes.
We can conclude that the strategy giving doxycycline treatment according to PCR+Rapid
tests is the most effective strategy when the hospital cost is not a factor.
We also observe that the best strategy depends on the prevalence of leptospirosis.
When the prevalence of leptospirosis is below 0.2, the strategy giving doxycycline treatment
according to PCR+Rapid tests result is the best strategy respect to deaths and DALYs, and
the strategy giving doxycycline treatment without any test is the best strategy respect to
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hospital costs for all four classes. However, when the prevalence of leptospirosis is higher
than 0.2, then the strategy giving doxycycline treatment without any test is the best strategy
respect to all three cost values for all four classes.
Based on the parameters in Tables 3.3-3.12 and vary the monetary cost per DALYs. The
strategy giving doxycycline treatment without any test is the best strategy as long as the
monetary cost per DALYs is not higher than $16,000 for late case severe symptoms class. The
strategy giving doxycycline treatment according to PCR+Rapid tests is the best strategy as
long as the monetary cost per DALYs is not too low for late case mild symptoms class. The
strategy giving doxycycline treatment without any test is the best strategy as long as the
monetary cost per DALYs is not higher than $12,000 for early case severe symptoms class.
The strategy giving doxycycline treatment without any test is the best strategy as long as
the monetary cost per DALYs is not higher than $14,000 for early case mild symptoms class.
The overall conclusion is that for all four classes, the strategy giving doxycycline
treatment according to PCR+Rapid tests is the best strategy as long as the prevalence
of leptospirosis is not high and the monetary cost per DALYs is not too low. When the
prevalence of leptospirosis is high, the strategy giving doxycycline treatment without any
test is always the best strategy for all four classes.
Early diagnosis of most diseases is crucial. However, the available technology is not always
able to detect many diseases in early stages. Most patients suffer or lose their life due to late
or inaccurate diagnosis. Some mathematical models can be developed with more complex
computational algorithms and statistical methods to support the physicians’ decision for
early detection of diseases. Our model compares the treatment strategies based on their
efficiencies and costs for the patients and for public health. The model indirectly maximizes
the number of early detected leptospirosis cases and also minimizes the corresponding costs.
The algorithm would be applicable to different types of diseases.
This chapter is collaboration with Prof. Suzanne Lenhart, University of Tennessee,
Knoxville, Prof. Claudia Munoz-Zanzi, University of Minnesota, Minneapolis, Prof. Ben
Fitzpatrick, Loyola Marymount University, Los Angeles, and Prof. Rudy A. Hartskeerl,
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A Summary of Equations
Theorem .1. If all the entries of NGM, K, are nonnegative and T is defined, then T ≥ 0.
Proof. Assume all the entries of K are nonnegative and T is defined. Since T is defined
ρ((I − Pi)K) < 1 and so (I − (I − Pi)K)−1 can be written




since all the entries of K are nonnegative, the remaining entries after removing the targeted
entries from K are nonnegative, therefore, the entires of (I−Pi)K are nonnegative. Since all
the entries of (I−Pi)K are nonnegative, all the entries of (I− (I−Pi)K)−1 are nonnegative.
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